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ABSTRACT




In applications such as studying drug adverse events (AE) in clinical trials and
identifying differentially expressed genes in microarray experiments, the data of the
experiments usually consists of frequency counts. In the analysis of such data,
researchers often face multiple hypotheses testing based on discrete test statistics.
Incorporating this discrete property of the data, several stepwise procedures, which
allow to use the CDF of p-values to determine the testing threshold, are proposed for
controlling familiwise error rate (FWER). It is shown that the proposed procedures
strongly control the FWER and are more powerful than the existing ones for discrete
data. Through some simulation studies and real data examples, the proposed
procedures are shown to outperform the existing procedures in terms of the FWER
control and power. An R package “MHTdiscrete” and a web application are developed
for implementing the proposed procedures for discrete data.
Many complex biomedical studies, such as clinical safety studies and genome-wide
association studies, often involve testing multiple families of hypotheses. Most existing
multiple testing methods cannot guarantee strong control of appropriate type 1 error
rates suitable for such increasingly complex research questions. A novel two-stage
procedure based on the recently developed idea of selective inference for clinical safety
studies is introduced. In the first stage, some significant families are selected by using
some family-level global test, which guarantees control of generalized familywise error
rate (k-FWER) among the selected families. In the second stage, individual hypotheses
are tested for each selected families by using some multiple testing procedure, which
controls conditional false discovery rate (cFDR) based on the fact that the family is
selected. By applying the proposed procedure to clinical safety studies, one can not only
efficiently flag the significant clinical adverse events (AEs) but also select body systems
of interest (BSoI) as extra information for further research. The simulation studies
show that the proposed procedure can be more reliable than alternative methods such
as Mehrotra and Heyse’s double FDR procedure in the setting of clinical safety. The
proposed procedure for multiple families structure is implemented in the R package
“MHTmult”.
Categorical data arises in biomedical and healthcare experiments naturally. In
many of these cases, the outcome variables of interest are the numbers of special events.
At least one distinct special event category is observed, when the negative multinomial
and extended negative multinomial or generalized inverse sampling scheme-based
regression models are used. The new model, based on generalized inverse sampling
scheme for several special events, is developed in this dissertation. This research is
an adaption to the widely used multinomial logistic regression model. The resulting
equations of the proposed model, corresponding to the natural log of the ratio of the
expected responses, appears similar to the multinomial logistic regression. Using this
expected response ratio of a category to that of the special category, the maximum
likelihood estimator of the regression parameters can be computed by creating score
equations and the Hessian matrix of the likelihood. The covariance matrix of estimators
of the regression parameters for the new model can be estimated by inverting the
Hessian matrix to develop the inference. This research also develops model diagnostics
such as normality check with deviance and Pearson residuals, and likelihood based
computations. The proposed model is implemented in the R package “mvlogit”.
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In the applications of clinical trials and genealogy study, multiple hypotheses testing
is a very useful statistical tool to analyze experimental data. Simultaneously testing
multiple hypotheses is often required in such applications. In single hypothesis testing,
a typical error measure which needs to be controlled is called type I error rate, the
probability of falsely rejecting the hypothesis while the hypothesis is true. There
are several possible measures for the overall type I error rate while testing multiple
hypotheses. A popular error rate is the familywise error rate (FWER), which is the
probability of making at least one false rejection. It is appropriate to control the
FWER when the number of hypotheses tested is small or moderate, but it is too
conservative when a large number of hypotheses are tested simultaneously which is
typically the case in large scale experiments like microarray or fMRI study. Benjamini
and Hochberg (1995) introduced false discovery rate (FDR) as an appropriate measure
to be controlled while simultaneously testing a large number of hypotheses. FDR is
defined as the expected proportion of false rejections among all rejections. To control
the FDR, it allows more hypotheses to be rejected while controlling the proportion
of false rejections, thus opening an opportunity for the development of more powerful
procedures than those using FWER as an error measure to control. For a review
of multiple testing procedures controlling the FWER, see Dmitrienko et al. (2009).
For a review of FDR controlling procedures, refer to Benjamini (2010). Most existing
procedures are constructed for continuous data, but these procedures may be highly
conservative when testing discrete data. Tarone (1990) proposed a modified Bonferroni
procedure to make it more powerful for discrete data. The modification is to reduce
the number of significance tests by eliminating those tests with relative large minimal
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attainable p-values. But the Tarone procedure lacks α-consistency, that is, a hypothesis
which is accepted at a given α level may be rejected at a lower α level (Roth, 1999). To
overcome this issue, two modified Tarone procedures were developed by Hommel and
Krummenauer (1998) and Roth (1999), which not only control FWER, but also have
the property of α-consistency. Hommel and Krummenauer (1998) improved the Holm
procedure to develop a step-down procedure for discrete data by using Tarone’s idea.
Roth (1999) presented a two-stage step-up procedure for improving Hochberg procedure
for discrete data based on the similar Tarone’s idea, but this step-up procedure lacks
α-consistency. Westfall and Wolfinger (1997) suggested a resampling based approach
to simulate the null distribution of minimal p-value, which uses the full set of attainable
p-values for each p-value. But this method is computationally complicated and only
ensure asymptotic control of the FWER. Gutman and Hochberg (2005) proposed new
stepwise procedures which use the Westfall and Wolfinger’s resampling algorithm and
the idea of Tarone procedure.
There are many adverse events (AE) classified by body systems (BS) in clinical
safety studies In clinical safety studies, there are many adverse events (AE) recorded
in one clinical trial. The goal for assessing the safety of an experimental drug is to
flag “reasonable” or “correct” AEs among these AE types. Most AE detecting or
flagging methods do not control for overall type 1 error rates, such as FWER or FDR.
Thus, similar as dealing with multiple endpoints in drug efficacy analysis, multiplicity
effect should be also considered in drug safety analysis. However, the number of AEs
in safety analysis is much larger than the number of endpoints in efficacy analysis
for the experimental drugs. Simply applying FWER controlling procedures such as
Bonferroni procedure may fail to flag more important AEs. Therefore, some FDR
controlling procedures such as BH procedure can be applied to detect the signals of
the AEs, since the number of AEs in clinical safety studies is usually large. Moreover,
searching for significant AEs, the AE types are often classified by several body systems
(BS). So the multiple-family structure should be considered for the drug safety data
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analysis. Recently, some structured BH-type procedures are developed for multiple
families of hypotheses (Mehrotra and Heyes, 2004; Mehrotra and Adewale, 2012; Hu et
al., 2010; Benjamini and Bogomolov, 2014). However, most existing methods do not
clearly separate the selection effect and multiplicity effect. To overcome this problem,
selective inference by using conditional inference such as conditional type 1 error rate
control, selection adjusted confidence interval is developed recently (Fithian et al., 2015;
Weinstein et al., 2013; Heller et al., 2016). By using the selective inference idea, the
second part of this dissertation introduces a multiple testing procedure for multiple
families structure in clinical safety studies.
In the last part of this dissertation, we highlight logistic-type model while
introducing generalized linear models for multi-level data. Logistic model is the most
important model for categorical response data. It is used increasingly in a wide variety
of applications, such as biomedical studies, social science researches, marketing, etc.
An area of increasing application of logistic model is genetics. For instance, Henshall
and Goddard (1999) used logistic regression to estimate quantitative trait loci effects,
modeling the probability that an offspring inherits an allele of one type instead of
another type as a function of phenotypic values on various traits for that offspring.
Levinson et al. (2000) used logistic regression for analysis of the genotype data of
affected sibling pairs (ASPs) and their parents from several research centers. The
model studied the probability that ASPs have identity-by-descent allele sharing and
tested its heterogeneity among the centers. In clinical trial experiments, the data are
usually collected as count data for several group/categories, where some categories are
classified as severe and rare diseases (or called “stages”), such as the data in Desmet
et al. (1994). We use this information in building our model, for more details, please
refer to Chapter 4.
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1.2 Basic Concepts of Multiple Hypotheses Testing
Consider simultaneously testing m hypotheses H1, . . . , Hm, based on the corresponding
p-values P1, . . . , Pm. Letm0 denote the number of true null hypotheses andm1 = m−m0
denote the number of false null hypotheses. Let I0 denote the set of indices of true null
hypotheses.
Let V denote the number of falsely rejected hypotheses, S denote the number of
correctly rejected hypotheses and R denote the total number of hypotheses rejected,
thus R = S + V . Table 1.1 summarizes the notations for all possible outcomes.










True Null Hypotheses m0 − V V m0
False Null Hypotheses m1 − S S m1
Total m−R R m
Note that m and m0 are fixed but m0 is usually unknown, R, V and S are random but
only R is observable, and V and S are unobservable.
When dealing with multiple testing problems, it is essential to choose an
appropriate overall measure of error rate and power measure.
1.2.1 Error Rate Definition
The overall error rate measure for multiple testing is not unique. Several commonly
used error rates are defined as follows.
4
• Per family error rate (PFER) is the expected number of incorrectly rejected
hypotheses, which is given by
PFER = E{V }.
• Comparisonwise error rate (CWER) is the proportion of falsely rejected hypotheses





• Familywise error rate (FWER) is the probability of making at least one false
rejection, which is given by
FWER = P{V > 0}.
• False discovery rate (FDR) is the proportion of falsely rejected hypotheses among














where R ∨ 1 = max{R, 1} and I(·) is indicator function. Note that when all null
hypotheses are true, that is m0 = m, FDR reduces to FWER. The relationship among
the above four error rate measures is CWER ≤ FDR ≤ FWER ≤ PFER.
1.2.2 Definition of Power
The power of a single test is defined as the probability of rejecting a false null
hypothesis. There are several types of power measure when testing multiple hypotheses
simultaneously, so it is important to use an appropriate power measure to evaluate
performance of a MTP. Several commonly used concepts of power are described below:
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• Minimal power is the probability of rejecting at least one false null hypothesis,
which is given by
Minimal Power = Pr(S > 0).
• Complete power is the probability of rejecting all false null hypotheses, which is
given by
Complete Power = Pr(S = m1).
• Average power is the expected proportion of rejected false null hypotheses among





• Another concept of power is from the false non-discovery rate (FNR), which is
given by






Theoretically, the definition of “universally more powerful” can be used to
compare two procedures.
Definition 1.1. If procedure A rejects all hypotheses rejected by procedure B for every
possible configuration, then we can say procedure A is universally more powerful than
procedure B.
1.2.3 Strong Control and Weak Control
Strong control is to control type I error rate under any combination of true and false
null hypotheses, while weak control is to control type I error rate only when all null
hypotheses are true. Generally, strong control of type I error rate is desired, since the
combination of true and false hypotheses in the actual setting is unknown.
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In applications of clinical trials, strong control of the FWER for the primary
objects is mandated by regulators. For example, in drug safety studies, the FWER
control is needed for the adverse events related to the trial drugs. For all other adverse
events, it is reasonable to control the FWER or the FDR.
1.2.4 Assumptions of p-values
• The p-value is calculated from given test statistic, thus the distribution of p-value
could be continuous or discrete based on the distribution of the test statistic.
Assumption 1.1. True null p-values are stochastically greater than or equal to
the U [0, 1] distribution, that is,
Pr(Pi ≤ u) ≤ u, for i ∈ I0 and u ∈ [0, 1]. (1.2.1)
We should note that the equality does not always hold in the assumption. For
instance, for finite discrete p-values, when u takes the values except attainable
p-values, “≤” in the above assumption becomes “<”. Only when u takes the
value of the attainable p-values, Pr(Pi ≤ u) = u. In Chapter 2, we will use this
property of discrete null p-values to develop some more powerful MTPs.
• Another assumption is the joint dependence structures of the p-values for multiple
hypotheses. Several dependence structures while developing MTPs are used
including: independence, block dependence (Storey, 2003; Guo and Sarkar, 2012),
positive regression dependence on subset (PRDS) (Benjamini and Yekutieli,
2001; Sarkar 2002), arbitrary dependence, which allows any dependence structure
including previous ones. The PRDS property is defined as follows.
Assumption 1.2. A set of p-values {P1 . . . Pm} is said to be PRDS, if for
any non-decreasing function of the p-values φ, E{φ(P1, . . . , Pm)|Pi ≤ p} is
non-decreasing in p for each true null hypothesis Hi.
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1.2.5 Distributions of the p-values for Discrete Data
We will now look into several typical discrete p-value distributions, which include the
Binomial Distribution, Hypergeometric Distribution.
Binomial distribution Consider testing a single hypothesis H0 : θ = θ0 versus H1 :
θ < θ0. Suppose that under H0, the test statistic X ∼ Bin(n, θ0). Then the attainable
p-value for this test can be calculated by pi = Pr(X ≤ i|H0) for i = 0, 1, . . . , n.
If the probability mass function (PMF) of Pi is Pr(P = pi), then the cumulative
distribution function (CDF) of the Pi is F (p) = Pr(P ≤ p) =
∑
pi≤p
Pr(P = pi). For
example, suppose X ∼ Bin(5, 0.3) under H0. Then the set of the attainable p-values
are {0.16807, 0.52822, 0.83692, 0.96922, 0.99757, 1}. The PMF and CDF of the p-value
can be given as
Pr(P = 0.16807) = Pr(X = 0) = 0.16807,
P r(P = 0.52822) = Pr(X = 1) = 0.36015,
P r(P = 0.83692) = Pr(X = 2) = 0.3087,
P r(P = 0.96922) = Pr(X = 3) = 0.1323,
P r(P = 0.99757) = Pr(X = 4) = 0.02835,





0, 0 ≤ p < 0.16807
0.16807, 0.16807 ≤ p < 0.52822
0.52822, 0.52822 ≤ p < 0.83692
0.83692, 0.83692 ≤ p < 0.96922
0.96922, 0.96922 ≤ p < 0.99757
0.99757, 0.99757 ≤ p < 1
1, p = 1.
(1.2.2)
The test statistic in binomial exact test (BET) follows binomial distribution.
Hypergeometric distribution Another popular discrete distribution is hyper-
geometric distribution Ti ∼ Hypergeometric(x1i, n1i, x·i, n·i), which describes the
probability of x1i successes in n1i draws, without replacement, from a finite population
of size n·i that contains exactly x·i successes, wherein each draw is either a success or a
failure.
For instance, let us consider the test statistics of Westfall and Wolfinger (1997)
in Table 1. In that example,
T1 ∼ Hypergeometric(5, 48, 5, 98),
T2 ∼ Hypergeometric(3, 48, 7, 98),
T3 ∼ Hypergeometric(4, 48, 4, 98),
T4 ∼ Hypergeometric(4, 48, 10, 98).
Note that each p-value is matched with corresponding test statistic, then we can find
PMF of the corresponding p-value Pi for each given Ti. For example,























Therefore, we can get CDF’s Fi of Pi, i = 1, . . . , 4, as follows:
F1(p) =

0, 0 ≤ p < 0.02521
0.02521, 0.02521 ≤ p < 0.16848
0.16848, 0.16848 ≤ p < 0.48047
0.48047, 0.48047 ≤ p < 0.80602
0.80602, 0.80602 ≤ p < 0.96880
0.96880, 0.96880 ≤ p < 1




0, 0 ≤ c < 0.00532
0.00532, 0.00532 ≤ p < 0.04967
0.04967, 0.04967 ≤ p < 0.20129
0.20129, 0.20129 ≤ p < 0.47697
. . . , . . .
0.99278, 0.99278 ≤ p < 1





0, 0 ≤ p < 0.05387
0.05387, 0.05387 ≤ p < 0.29327
0.29327, 0.29327 ≤ p < 0.67580
0.67580, 0.67580 ≤ p < 0.93625
0.93625, 0.93625 ≤ p < 1





0, 0 ≤ p < 0.00047
0.00047, 0.00047 ≤ p < 0.00645
0.00645, 0.00645 ≤ p < 0.03946
0.03946, 0.03946 ≤ p < 0.14250
. . . , . . .
0.99927, 0.99927 ≤ p < 1
1. c = 1.
(1.2.6)
Figure 1.1 shows the CDF’s of true null p-values for these four tests.
Fisher’s exact test (FET) is usually used to test association between two
variables of interest for a 2 × 2 contingency table. The test statistic in FET follows
hypergeometric distribution.
Remark 1.1. χ2 test and Fisher exact test are two popular approaches used for
analyzing Adverse Events (AEs) data. Fisher’s exact test is desired when the expected
draws (x1i) is small.
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Figure 1.1 The values of the p-value Pi versus the values of the CDF Fi for i =
1, . . . , 4.
1.2.6 α-consistency
In hypothesis testing, α-consistency is a type of desired statistical property in terms of
the significant level α, which is defined as follow:
Definition 1.2. A hypothesis that is rejected at a given α level must be rejected at a
higher α level. This property is called α-consistency.
For single hypothesis testing, it is trivial that this property is satisfied. For
multiple hypotheses testing, not all procedures have this property. Here α-consistency
means when α becomes larger, the set of rejections determined by the MTP will not
become smaller.
1.2.7 p-value Monotonicity
Another favorable property of a multiple testing procedure is monotonicity in terms of
p-values, which can be defined as follow:
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Definition 1.3. If one or more p-values are made smaller, then at least the same or
even more hypotheses would be rejected for the same procedure. We say such a procedure
is p-value monotone.
It is easy to see that the property of p-value monotone is always satisfied by
stepwise procedures. It is an essential requirement for multiple testing procedures.
1.2.8 Adjusted p-value
It is very useful to calculate adjusted p-value in multiple testing, since adjusted p-values
capture the degree of multiplicity adjustment, so that we can make decisions of rejection
and acceptance as in single hypothesis by comparing the adjusted p-values with the
given significance level. Decision rules based on adjusted p-values are equivalent to
ones based on original procedures.
A general definition of an adjusted p-value is given in Westfall and Young (1993):
the adjusted p-value for a hypothesis is the smallest significance level at which one
would reject the hypothesis using the given multiple testing procedure. Let P̃i denote
the adjusted p-value corresponding to Hi, which is given by
P̃i = inf{α : Hi is rejected using the given procedure at level α}. (1.2.7)
If this procedure controls FWER/FDR at level α, then
P̃i = inf{α : Hi is rejected when FWER/FDR is controlled at level α}. (1.2.8)
So we can make the decision based on adjusted p-values: reject Hi if P̃i ≤ α. This
calculation can help researchers make decisions easily and fast.
1.3 Multiple Testing Procedures (MTPs)
Several multiple testing procedures have been developed in the literature for various
scenario. They can be broadly classified as three main types: p-value based MTP,
parametric MTP and resampling based MTP.
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• p-value based MTP : These procedures do not make any assumptions about the
joint distribution of the test statistics and only rely on the univariate p-values.
Typical examples are Bonferroni (1936) procedure, Holm (1979) procedure, BH
(1995) procedure.
• parametric MTP : These procedures make specific assumptions about the distri-
bution of the test statistics. For instance, the joint distribution might be a
multivariate normal or a multivariate t-distribution. A typical procedure is
Dunnett procedure (1955).
• resampling based MTP : These procedures use resampling techniques like bootstrap,
permutation, etc., that make fewer assumptions about the data-generating process
while still exploiting the dependence structure of the underlying test statistics in
multiple testing procedures, see Westfall and Young (1993).
1.3.1 Multiple Testing Procedures based on p-values
The first two parts of this dissertation mainly focuses on p-value based MTPs.
Commonly, the p-value based MTPs test hypotheses step by step. According to the
order of p-values, the MTPs can be classified as single-step, step-down, and step-up
procedures.
Let P(1) ≤ · · · ≤ P(m) be the ordered p-values and H(1), . . . , H(m) be the
corresponding hypotheses. By using a sequence of non-decreasing critical constants
α1 ≤ · · · ≤ αm, the stepwise MTPs are described as follows:
• Single-step procedure compares p-values with the same critical constant c, that
is, reject Hi if Pi ≤ c for i = 1, . . . ,m. A widely used single-step procedure is




• Step-down procedure starts with the most significant hypothesis H(1) corre-
sponding to the smallest p-value P(1), If P(1) > α1, accept all m hypotheses;
otherwise, keep rejecting hypotheses until an acceptance is observed. The
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rest hypotheses are accepted automatically. That is, the procedure rejects
H(1), . . . , H(r), accept H(r+1), . . . , H(m), where r is the largest index satisfying
P(1) ≤ α1, . . . , P(r) ≤ αr. A typical example is Holm procedure (Holm, 1979),




• Step-up procedure starts with the least significant hypothesis H(m) corresponding
to the largest p-value P(m). If P(m) ≤ αm, reject all m hypotheses; otherwise,
keep accepting hypotheses until a rejection is observed. The rest hypotheses
are rejected automatically. That is, the procedure rejects H(1), . . . , H(r), accept
H(r+1), . . . , H(m), where r is the largest index satisfying P(r) ≤ αr.
A typical example is Hochberg procedure (1988), which is a step-up procedure
with the same critical constants as Holm procedure.
1.3.2 FWER Controlling Procedures
A well known FWER controlling procedure is the Bonferroni procedure (1936), which
is a single-step procedure with the critical constant c =
α
m
. A more powerful single-step
procedure is the Sidak procedure (1967), which has the critical constant 1− (1− α) 1m .
The critical constant is slightly larger than that of the Bonferroni procedure. Holm
(1979) developed a step-down procedure we have defined in last subsection with the
critical constant αi =
α
m− i+ 1
, which strongly controls the FWER under arbitrary
dependence. Hochberg (1988) proposed a step-up procedure with the same critical
value as the Holm procedure, which controls the FWER under the PRDS property.
Taking discrete property of statistics into account, Tarone (1990) introduced a
modified Bonferroni procedure by using the smallest attainable p-values to eliminate
the non-significant tests. The critical constant of this modified procedure is larger
than that of Bonferroni procedure, which implies this procedure is more powerful than
Bonferroni procedure.
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I{p∗i < α/k} ≤ m. Define Kα = min{1 ≤ k ≤ m : Mα(k) ≤ k} and
RKα = {i : p∗i <
α
Kα
}. Then reject Hi if i ∈ RKα and Pi < α/Kα.
Remark 1.2. Note that in the definition of Procedure 1.1, since Pi ≥ p∗i , Pi < α/Kα
implies i ∈ RKα = {i : p∗i <
α
Kα
}. That means rejecting Hi only needs Pi < α/Kα.
Note that for continuous p-values Mα(k) = m for k = 1, . . . ,m, so Kα = m and
Procedure 1.1 reduces to Bonferroni procedure.
Unfortunately, the Tarone procedure lacks α-consistency. For example, suppose
we simultaneously test two hypotheses H1 and H2 with the corresponding actual p-
values being P1 = 0.07 and P2 = 0.1. The smallest attainable p-values for H1 and H2
are p∗1 = 0.06 and p
∗
2 = 0.08, respectively. When α = 0.1, Mα(1) = 2 and Mα(2) = 0,
so Kα = 2. Thus, no any hypothesis is rejected since P1 and P2 are larger than
α/Kα = 0.05. However, when α = 0.075, Mα(1) = 1 and Mα(2) = 0, so Kα = 1
and α/Kα = 0.075. Therefore H1 is rejected since P1 = 0.07 < 0.075. Thus, when α
becomes smaller, more hypotheses can be rejected. That is, the Tarone procedure does
not satisfy the property of α-consistency.
To overcome the issue of lacking α-consistency, Hommel and Krummenauer (1998)
developed a modified Tarone procedure, which is proved satisfying the property of
α-consistency.
Procedure 1.2 (T ∗). Suppose p∗i is the smallest attainable p-value for Hi and let
γ ∈ (0, α] and Mγ(k) =
m∑
i=1
I{p∗i < γ/k}. Define Kγ = min{1 ≤ k ≤ m : Mγ(k) ≤ k},
then reject Hi if there exists a γ, such that Pi ≤ γ/Kγ
In Procedure 1.1, k and Kα can only take integer values from 1 to m, Roth (1999)
suggested another modified Tarone procedure allowing k and Kα to take fractional
values. The critical constant α/Xα introduced in the following procedure will be
continuous and monotone. Thus it retains α-consistency.
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}. Define Xα = inf{1 ≤ x ≤ m : Mα(x) ≤ x}, then reject Hi
if Pi < α/Xα.
Roth (1999) showed that Procedure 1.3 is equivalent to Procedure 1.2 and these
two procedures are universally more powerful than Tarone procedure.
Hommel and Krummenauer (1998) also proposed a step-down procedure for
discrete data by incorporating Tarone’s idea into Holm procedure.
Procedure 1.4 (TH∗).
1. Set I = {1, . . . ,m}.
2. For k = 1, . . . , |I|, define MI(k) = #{i ∈ I : p∗i ≤ α/k} as the number of
hypotheses with indices in I that can be rejected at level α/k. Let KI(α) =




3. For i ∈ I, reject Hi if and only if Pi ≤ bI(γ) for some 0 < γ ≤ α.
4. Let J be the index set of hypotheses rejected in step 3.
5. If J is empty then stop, otherwise set I = I − J and return to step 2.
Note that if the test statistics is continuous, then Procedure 1.4 reduces to Holm
procedure.
Roth (1999) also introduced a two stage step-up procedure based on Hochberg
procedure (1998).
Procedure 1.5. Roth’s step-up procedure is consisted of the following two stages:
• Stage 1:
1. Accept all hypotheses outside of R1 = {Hi : p∗i < α}.
2. For the Mα(1) hypotheses in the set R1, order their available p-values from
highest to lowest as P1,(1) ≥ · · · ≥ P1,(Mα(1)) with corresponding hypotheses
H1,(1), . . . , H1,(Mα(1)).
3. Define r = min{j : P1,(j) < αj and H1,(j) ∈ R1}.
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1. Consider only the hypotheses in RK ,, order their available p-values from
highest to lowest by PK,(1) ≥ · · · ≥ PK,(Mα(K)). If Mα(K) < K, then let
PK,(i) = 0 for i = Mα(K) + 1, . . . , K, where K is the same as Kα defined in
Procedure 1.1.
2. For j = 1, . . . , K, define P ∗j = max{{Pj,(j)}
⋃
{Pi : Hi ∈ Rj −RK}}.








Then this procedure rejects Hi if it was rejected in stage 1 or 2.
Adjusted p-value for several existing procedures
Based on (1.2.8), adjusted p-value for the Bonferroni procedure for each hypothesis Hi
can be obtained by
P̃i,Bonf = min{1,mPi}, where i = 1, . . . ,m.
The adjusted p-value for the Sidak procedure is given by
P̃i,Sidak = 1− (1− Pi)m, where i = 1, . . . ,m.
The adjusted p-values for Procedure 1.2 is defined by Hommel and Krummernauer
(1998) as follow.
Proposition 1.1. Adjusted p-value for Procedure 1.2 (T ∗) Order the minimal




, the adjusted p-value is
P̃i,T ∗ = min{1, q(Pi) · Pi}, for i = 1, . . . ,m. (1.3.1)
The adjusted p-value for Holm procedure (1979) can be obtained as follow:
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1, (m− i+ 1)P(i)
}}
, i = 2, . . . ,m
Hommel and Krummenauer (1998) obtained an algorithm for computing the
adjusted p-values for Tarone-Holm Procedure 1.4 as follow:
Proposition 1.3. Adjusted p-value for Procedure 1.4 (TH∗)
1. Set j = 1. Let indices i1, . . . , im according to ordered p-values P(1) < P(2) < · · · <
P(m). Determine q = q(P(1)) such that p
∗




P̃(1),TH∗ = min{1, q(P(1)) · P(1)}.
2. Set j = j + 1,
3. Set I = {(j), (j + 1), . . . , (m)} = {i1, ..., it} with t = m − j + 1 and i1 < ... < it.
Determine q = q(P(j)) such that p
∗
iq < P(j) < p
∗
iq+1
If P(j) > αi∗t , choose q(P(j)) = t.
4. Compute
P̃(j),TH∗ = max{P̃(j−1),TH∗ ,min{1, q(P(j)) · P(j)}}
5. If j = m, stop; otherwise go back to step 2.
The adjusted p-value of Hochberg procedure (1988) is derived as follow:
Proposition 1.4. The adjusted p-value of Hochberg procedure for each hypothesis H(i)
is defined by
P̃(i),Hochberg =
P(m), i = mmin{P̃(i+1),Hochberg, (m− i+ 1)P(i)} , i = m− 1, . . . , 1
In addition, Gutman and Hochberg (2007) proposed single-step and stepwise
procedures by using the Westfall and Wolfinger procedure on the set RK defined in
Procedure 1.1. Kulinskaya and Lewin (2009) proposed a fuzzy Bonferroni procedure
19
based on the idea of randomized test, but the interpretation of the results is not very
straightforward.
1.3.3 FDR Controlling Procedures
In some experimental settings such as DNA microarray experiments, genome-wide
association studies (GWAS), functional Magnetic Resonance Imaging (fMRI) exper-
iments and adverse events detection in clinical trials, there are a large number
of hypotheses. Familywise Error Rate (FWER) controlling procedures are quite
conservative for such testing problems. Benjamini and Hochberg (1995) introduced
the False Discovery Rate (FDR) as an alternative error measure to the FWER. They
also introduced BH procedure for controlling FDR, which is a simple step-up procedure
with the critical constant of αi =
i
m
α. Benjamini and Yekutieli (2001) show that
BH procedure controls the FDR under PRDS condition. They also introduced BY






i=1 1/i. BY procedure controls FDR under arbitrary dependence.
Benjamini and Liu (1999) and Romano and Shaikh (2006) proposed two different
step-down procedures which can control FDR under certain conditions. Storey (2002,
2004) introduced an estimation approach to FDR that is the opposite of stepwise
methods. In the stepwise methods, the rejection region (critical constants) is determined
based on the fixed FDR level, but Storey’s approach is to fix the rejection region and
estimate the FDR of the rejection region. For some other methods, see Sarkar (2008)
and Benjamini (2010).
Adjusted p-value for FDR controlling procedure
The adjusted p-value of BH procedure is derived as follow:
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Proposition 1.5. The adjusted p-value of BH procedure for each hypothesis H(i) is
defined by
P̃(i),BH =




, i = m− 1, . . . , 1
The BH procedure can be used for developing conditional FDR controlling
procedure in Chapter 3.
1.4 Research Motivation and Dissertation Outline
In this dissertation, we focus on developing some new methods for analyzing biomedical
or clinical data. In Chapter 2, several stepwise multiple testing procedures are proposed
for real data applications, that take the discreteness of the test statistics into account,
and control FWER as required by the problem of interest. In Chapter 3, by exploiting
selective inference idea, one class of two-stage multiple testing procedures are developed
for controlling type 1 error rates for different levels based on the multiple families
structure. The proposed procedure can efficiently select body system of interest and flag
adverse events in clinical safety studies. In Chapter 4, a logistic-type model considering
an inverse sampling scheme is established for modeling categorical data, which shares
common covariates in each sample. In the following, we discuss the motivation behind
the research.
In clinical trials, discrete data often arise and FWER control is commonly required
while testing multiple hypotheses. In the literature, most FWER controlling procedures
are developed for continuous data. By fully exploiting the discrete information, we can
generally develop more powerful procedures than the usual ones. Previous researches on
FWER control procedures for discrete data are either based on the partial information
of p-values (minimal attainable p-value), or resampling and randomization methods
which needs intensive computation but only ensured asymptotic control of the FWER.
For example, Tarone procedure only uses the minimal attainable p-value to reduce the
number of tested hypotheses. In practice, the CDF of the null p-values are often known
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for discrete data. By using the distributional information of the null p-values, we can
develop more powerful FWER controlling procedures for discrete data.
In many modern applications, it may be more appropriate to apply a multiple
testing procedure that controls FDR. One such application is to study clinical safety for
drug development, which collect and monitor spontaneous reports of suspected adverse
events from health care providers. In order to detect new adverse drug reactions after
marketing approval, we can use multiple testing methods to test the association between
drugs and adverse events while controlling the FDR. Since the adverse events are
naturally classified by different body system, a two-stage multiple testing procedure is
considered, where the first stage is to select body systems for further research discovery,
and the second stage is to flag AE in selected body systems. It is desired to control type
1 error rates for both screening and testing stages. Since the selection and testing stages
use the same data, the selective (conditional) inference should be taken into account.
This application also motivates to develop a GLM model in Chapter 4. When
the response is categorical data, with several level as rare ones, but the covariates
are the same in each sample, the traditional logistic model or ENMn model is not
suitable any more. We suggest a logistic-type model with the response following ENMn
distributions. We can make corresponding inference, such as parameter estimation,
confidence interval, hypotheses testing, etc. Real data analysis and comparisons are
performed as well.
This dissertation is outlined as follows: Chapter 1 provides some basic concepts
on multiple testing and background on generalized linear model. In Chapter 2, several
stepwise FWER controlling procedures for discrete data are proposed. We also compare
our proposed procedures with some existing MTPs through real data analysis and
simulation studies. In Chapter 3, we develop a two-stage selective inference based
multiple testing procedures for multiple families structure, which can be well applied in
clinical safety data analysis. Simulation studies through which we compare the proposed
procedure with other procedures for multiple families are also presented. In Chapter
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4, a multivariate logistic-type model based on an inverse sampling scheme is developed
for modeling categorical data including several special and non-special event groups,
statistical inference and model diagnostics for the proposed model in comparison with
conventional logistic regression are also provided.
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CHAPTER 2
FWER CONTROLLING PROCEDURES FOR DISCRETE DATA
2.1 Introduction
In this chapter, we consider to develop several FWER controlling procedures for
discrete data. In the existing literature, most FWER controlling procedures are
developed for continuous data, such as Bonferroni procedure (1936), Holm procedure
(1979) and Hochberg procedure (1988), etc. These procedures control FWER under
various dependence condition. However, they might be highly conservative when
they are used to analyze discrete data. A few of researches have been devoted to
develop FWER controlling procedures for discrete data. Tarone (1990) improved
Bonferroni procedure by using the minimal attainable p-value, which reduces the actual
number of hypotheses by removing the non-significant ones. The modified Bonferroni
procedure controls the FWER under arbitrary dependence and is more powerful than
the original Bonferroni procedure for discrete test statistics. But Tarone’s procedure
lacks α-consistency (Roth, 1999). To overcome this problem, two types of improved
Tarone procedures were developed by Hommel and Krummenauer (1998) and Roth
(1999), which not only control FWER, but also maintain α-consistency. Furthermore,
Hommel and Krummenauer (1998) incorporated Tarone’s idea to improve the Holm
procedure for discrete data. By using the similar idea, Roth (1999) introduced a two
stage step-up procedure based on Hochberg procedure (1988). However, this procedure
lacks α-consistency.
In this chapter, we introduce several FWER controlling procedures that exploits
the discrete nature of test statistics. We first consider a single-step modified Bonferroni
procedure using CDF’s of p-values, which exploits enough information of discrete p-
values. Compared with existing single-step methods, the proposed procedure has several
good properties. It is more powerful than the existing single-step procedures for discrete
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data. By using similar idea, we also develop step-down and step-up procedures for
discrete data. The proposed procedures not only control the FWER, but also have
α-consistency and p-value monotonicity, which are desired properties in multiple testing.
Adjusted p-value of the proposed procedures can also be easily calculated, while closed-
forms of adjusted p-values are very difficult to obtain for resampling based methods
or randomized tests. We illustrate an application for detecting differentially expressed
cDNA transcripts among multiple nucleotides, where the experiments are conducted
by using discrete data. Through real data analysis and simulation studies, we compare
the performances of the proposed methods with those of the available procedures.
The rest of the chapter is organized as follows. Section 2.2 introduces some
basic notations, concepts and existing procedures for discrete data. In Section 2.3, the
new single-step procedure is proposed and some desired statistical properties of this
procedure are discussed. Section 2.4 and 2.5 respectively introduce new step-down and
step-up procedures for discrete data to control the FWER. Section 2.6 summarizes and
discusses some future work. Statistical computing tools such as R package and web
application are also developed.
2.2 Preliminary
Consider the problem of simultaneously testing m hypotheses H1, . . . , Hm, suppose
there are m0 true null hypotheses and m1 false null hypotheses. Assume the test
statistics are discrete. Let Pi denote the p-value for testing Hi and Pi denote the
full set of all attainable p-values for Hi such that Pi ∈ Pi. Suppose Fi denote the
cumulative distribution function (CDF) of Pi when Hi is true, that is Fi(u) = Pr(Pi ≤
u|Hi is true). For any u ∈ Pi, Fi(u) = u; otherwise, Fi(u) < u.
Typically, the hypotheses are ordered based on their p-values and are tested using
a single-step or stepwise procedure. Let P(1) ≤ · · · ≤ P(m) denote the ordered p-values
and H(1), . . . , H(m) denote the corresponding hypotheses. Let F(i) denote the CDF of
P(i) when H(i) is true, and P(i) denote the set of all attainable p-values of P(i).
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2.3 A Single-step Procedure for Discrete Data
A simple and commonly used single-step procedure is Bonferroni procedure, which
rejects Hi if Pi ≤
α
m
. The Bonferroni procedure controls FWER under arbitrary
dependence. Taking discreteness of data into account, Tarone (1990) proposed a novel
single-step procedure (Procedure 1.1) controlling FWER, which is more powerful than
Bonferroni procedure. However, the procedure only use partial information of true null
distributions, so it might be conservative. In this section, we consider using full sets of
discrete p-values to develop a more powerful single-step procedure.
2.3.1 A New Single-step Procedure
In this subsection, we present a new single-step procedure for discrete data. The
proposed procedure fully exploits the marginal distribution of the true null p-values,
and is defined as follow:










if the maximum does not exist. Then reject Hi if its corresponding p-value
Pi ≤ t.
Remark 2.1. It should be noted that the proposed modified Bonferroni procedure 2.1
for discrete data is a natural extension of the usual Bonferroni method for continuous
data. When all true null test statistics have continuous distributions, which implies




critical value of Bonferroni procedure. Thus, the above procedure reduces to Bonferroni
procedure.
In the following, we prove that Procedure 2.1 strongly controls the FWER under
arbitrary dependence.
Theorem 2.1. Procedure 2.1 strongly controls the FWER at level α under arbitrary
dependence.
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Proof. Let V denote the number of falsely rejected hypotheses, I0 denote the index set
of true null hypotheses with |I0| = m0, then

















The first inequality follows from Bonferroni inequality.
If the maximum does not exist, by using the property of the CDF for discrete






t = m · α
m
= α. The proof is complete.
In the following, we compare the proposed method with several existing single-
step procedures, and prove that the proposed procedure is more powerful than these
procedures. First of all, we want to show the proposed procedure is more powerful than
Tarone’s procedure, which is described in supplementary materials.
Proposition 2.1. Procedure 2.1 is universally more powerful than Procedure 1.1.







Since RKα = {i : p∗i <
α
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Fi(p) ≤ α}, and let t∗ be the smallest attainable


















) ≤ α, so α
Kα




it is trivial the set of rejections using Tarone’s procedure is no more than the Procedure
2.1; (2) when t <
α
Kα
< t∗, by the property of discreteness, {Hi : Pi ≤ t} = {Hi : Pi <
α
Kα
} = {Hi : Pi < t∗}. So based on (1) and (2) rejection set using Tarone’s procedure
is less than or equal to the one using Procedure 2.1.
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Therefore, Procedure 2.1 always rejects as many hypotheses as Tarone’s procedure.
That is, Procedure 2.1 is universally more powerful than Tarone’s procedure.
We can also show that the proposed procedure is more powerful than modified
Tarone’s Procedure.
Proposition 2.2. Procedure 2.1 is universally more powerful than Procedure 1.2.







Let RKγ = {i : p∗i <
γ
Kγ



















≤ γ ≤ α.
(2.3.2)
The rest of argument is similar as the proof of Proposition 2.1 and the conclusion
follows.
So far, we have shown the new single-step procedure is more powerful than the
Tarone’s procedure and its modified versions for discrete data. Next, we look into some
other good properties of this procedure.
α-consistency
Proposition 2.3. Procedure 2.1 is an α-consistent procedure.






Fi(p) ≤ α}. It is equivalent to show that the
threshold t is a non-decreasing function in α. It is trivial.
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p-value monotonicity Based on (2.3.3), it is easy to show Procedure 2.1 has p-
value monotonicity. Since for each i, true null CDF Fi(·) is a non-decreasing function,
m∑
i=1
Fi(·) is also a non-decreasing function. When some p-values become smaller, the
corresponding adjusted p-values will not become larger, thus the procedure will reject
the same hypotheses and possibly more. So we have the following proposition.
Proposition 2.4. Procedure 2.1 is p-value monotone.
Adjusted p-value Now, we can derive the adjusted p-value for our proposed
procedure as follow:
Proposition 2.5 (Modified Bonferroni Procedure 2.1).









, for i = 1, . . . ,m. (2.3.3)
It is easy to see that the adjusted p-value of the proposed modified Bonferroni
procedure is smaller than or equal to that of original Bonferroni procedure, since for
each fixed i and any j = 1, . . . ,m, Fj(Pi) ≤ Pi, then
m∑
j=1
Fj(Pi) ≤ mPi. Therefore,
the Procedure 2.1 could have more rejections than Bonferroni procedure for the same
available p-values.
In the following, we compare the adjusted p-values of the proposed Procedure 2.1
with those of Bonferroni procedure and Procedure 1.2 through a simple example.
Example 2.1. Suppose there are m = 2 hypotheses H1 and H2, the attainable p-values
for H1 is P1 = {0.05, 1}; for H2 is P2 = {0.1, 1}. The actual p-values are P1 = 0.05, P2 =
0.1. Thus the minimal attainable p-values are p∗1 = 0.05, p
∗
2 = 0.1. Now we can
calculate the adjusted p-values for Bonferroni procedure are P̃1,Bonf = 2×P1 = 0.1 and
P̃2,Bonf = 2× P2 = 0.2.
To calculate the adjusted p-value of Procedure 1.2, firstly we need to determine
q. For P1 = 0.05, p
∗
1 ≤ P1 < p∗2, so q = 1, P̃1,T ∗ = 1 × P1 = 0.05. For P2 = 0.1,
since P2 ≥ p∗2, then q = m = 2, P̃2,T ∗ = 2 × P2 = 0.2. The CDF of p-values for
29
the two hypotheses can be expressed by F1(c) = 0.05 × I{0.05 ≤ c < 1} + I{c = 1},
F2(c) = 0.1×I{0.1 ≤ c < 1}+I{c = 1}, where I is an indicator function. So P̃1,MBonf =
F1(0.05)+F2(0.05) = 0.05+0 = 0.05, P̃2,MBonf = F1(0.1)+F2(0.1) = 0.05+0.1 = 0.15,
which are smaller than those of the Bonferroni procedure and Procedure 1.2.
Now, suppose we set the significant level α = 0.06, then by comparing the adjusted
p-values of the above procedures with α, we can conclude the Bonferroni procedure
reject no hypothesis, Procedure 1.2 and Procedure 2.1 reject H1. But if set α = 0.16, the
Bonferroni procedure and Procedure 1.2 only reject H1, while the proposed Procedure
2.1 rejects H1 and H2.
2.3.2 Applications for Single-step Procedures
cDNA transcripts data Tarone (1990) analyzed an experiment in which comple-
mentary DNA (cDNA) transcripts were produced from transcribed RNA obtained from
cells grown under normal conditions and from cells grown under an unusual study
condition. The cDNA transcripts from a gene of interest were sequenced and compared
to the known nucleotide sequence to determine the number of individual nucleotide
changes in the transcripts. The frequencies of the changes were compared from the
control and study cells to evaluate differences in the transcribed RNA.
The data in Table 2.1 is from Hommel and Krummenauer (1998, Table 1), which
reports the frequencies of nucleotide changes observed at nine sites. The DNA sequences
examined in the experiment were 200 nucleotides in length. Our analysis includes nine
changed nucleotides, which are those with a sufficient number of changes to possibly
detect statistical significance at the significant level α = 0.05 using the Fisher’s Exact
Test (FET), conditional on the fixed marginal totals, and assuming independence
between sites. In the data, Nji is the number of transcripts at nucleotide i in group
j and Xji is the observed number of change in transcripts, which is the events of
interest, where i = 1, ..., 9 and j = 0, 1 (0 is control group and 1 is study group). The
first column shows the index of the ordered nucleotide p-values reported in Hommel
and Krummenauer (1998). The second and third columns are the frequencies of the
observed change in the control and study groups. The nucleotides available p-values Pi
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where X·i = X0i+X1i, N·i = N0i+N1i. For Tarone’s procedure, the minimal attainable









Table 2.1 A Comparison of Adjusted p-values for the Bonferroni Procedure, Sidak
Procedure, Modified Tarone Procedure and Procedure 2.1 when Testing the Hypotheses
in the cDNA Example from Hommel and Krummenauer (1998)
i X0i/N0i X1i/N1i Pi P̃i,Bonf P̃i,Sidak P̃i,T ∗ P̃i,MBonf
1 1/10 8/11 0.0058 0.0522 0.0510 0.0116 0.0097
2 0/8 5/7 0.0070 0.0629 0.0612 0.0210 0.0167
3 0/11 4/10 0.0351 0.3158 0.2749 0.2100 0.1072
4 1/11 3/9 0.2167 1.0000 0.8890 1.0000 0.6184
5 2/11 4/10 0.2678 1.0000 0.9395 1.0000 1.0000
6 1/10 3/10 0.2910 1.0000 0.9547 1.0000 1.0000
7 2/9 2/8 0.6647 1.0000 1.0000 1.0000 1.0000
8 2/9 2/9 0.7118 1.0000 1.0000 1.0000 1.0000
9 2/9 2/9 0.7118 1.0000 1.0000 1.0000 1.0000
From Table 2.1, we can see that for nucleotide i = 1, . . . , 4, the adjusted p-values
of Procedure 2.1 are smaller than those of other traditional procedures, which implies
these hypotheses are more likely to be rejected by the Procedure 2.1 than others.
Clinical safety data We can also apply the proposed single-step procedure for
clinical safety studies, since clinical safety data is usually based on the count of patients
to illustrate the adverse events exposures. The data in Table 2.2 (first three columns)
are from Mehrotra and Heyse (2004, Table 1), which reports the AE types for two groups
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of toddlers for Body System 10. For illustration purpose, we reorder the data based on
the corresponding p-values. The goal of this clinical safety study is to detect significant
AEs (so-called “flagging”). Our analysis includes nine AE types of No. 10 body system
(skin), which are those with a sufficient number of AE types to possibly detect statistical
significance at the significant level α = 0.05 using the Fisher’s Exact Test (FET),
conditional on the fixed marginal totals, and assuming independence between sites. In
the data, Nj is the total number of toddlers at group j, and Xji is the observed number
of the j-th group toddlers experiencing the i-th AE, which is the events of interest,
where i = 1, ..., 9 and j = 1, 2 (1 is control group receiving MMR and 2 is study group
receiving the candidate vaccine MMRV). Here N1 = 148 and N2 = 132. The first
column shows the index of the AE types after reordering the data. The second and
third columns are the number of toddlers experiencing the corresponding AE in the
control and study groups. The available p-values Pi for i-the AE type in Table 2.2 are
calculated by using two-sided FET.
Table 2.2 A Comparison of Adjusted p-values for the Bonferroni Procedure, Sidak
Procedure, Procedure 1.2 and Procedure 2.1 when Testing the Hypotheses for Nine AE
types of Body System 10 in the Clinical Safety Data Example from Mehrotra and Heyse
(2004), where the Numbers of Patients for Two Groups Are N1 = 148 and N2 = 132
i X1i X2i Pi P̃i,Bonf P̃i,Sidak P̃i,T ∗ P̃i,MBonf
1 13 3 0.0209 0.1880 0.1731 0.0836 0.0534
2 8 1 0.0388 0.3490 0.2995 0.1551 0.1343
3 4 0 0.1248 1.0000 0.6986 0.8734 0.7134
4 0 2 0.2214 1.0000 0.8948 1.0000 1.0000
5 6 2 0.2885 1.0000 0.9533 1.0000 1.0000
6 2 0 0.4998 1.0000 0.9980 1.0000 1.0000
7 1 2 0.6033 1.0000 0.9998 1.0000 1.0000
8 4 2 0.6872 1.0000 1.0000 1.0000 1.0000
9 2 1 1.0000 1.0000 1.0000 1.0000 1.0000
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From Table 2.2, we can see that for the first three AE p-values P1, . . . , P3,
the adjusted p-values of Procedure 2.1 are smaller than those of other traditional
procedures, which implies these hypotheses are more likely to be rejected by the
Procedure 2.1 than others, that is, those AE are more easily flagged by using the
Procedure 2.1.
2.3.3 Simulation Studies for Single-step Procedures Comparisons
In the following, simulation studies were performed to investigate the performances
of the proposed Procedures 2.1 in terms of the FWER control and minimal power
compared with some existing single-step FWER controlling procedures.
Basic settings of the simulation The simulations are conducted based on two
typical discrete tests: Fisher’s Exact Test (FET) and Binomial Exact Test (BET).
1. Fisher’s Exact Test: Suppose we have two groups, study (1) and control (2)
group. There are m independent binomial responses Xij observed for each of N
individuals in each group i, such as Xi1 ∼ Bin(N, pi1), Xi2 ∼ Bin(N, pi2) for
i = 1, . . . ,m. The goal is to simultaneously test the m hypotheses Hi : pi1 = pi2,
where pij is the success probability for the i-th response in group j, and i =
1, . . . ,m, j = 1, 2. So there are m of 2×2 contingency tables in each simulation as
described in Chapter 1. We conduct the experiment using one-sided FET under
α = 0.05, then the test statistic Ti ∼ Hypergeometric(Xi1, N,Xi1 + Xi2, 2N).
Set the number of hypotheses m = {5, 10, 15}, with true null proportion π0 =
{0.2, 0.4, 0.6, 0.8} respectively. The sample size for the binomial response per
group used are N = {25, 50, 75, 100, 125, 150}. For true null hypotheses, set the
success probability parameter of binomial response in each group as 0.1, and for
false null hypotheses set the success probability for study group as 0.1, and for
control group as 0.2. The observed individuals in the two groups are chosen
randomly from the Binomial distributions.
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2. Binomial Exact Test: Suppose we have two groups: study (1) and control (2)
group. There are m Poisson responses observed in each group, such as Xi1 ∼
Poi(λi1), Xi2 ∼ Poi(λi2) for i = 1, . . . ,m. The goal is to simultaneously test the
m hypotheses Hi : λ1i = λ2i, where λij is the mean parameter for the i-th response
in group j, and i = 1, . . . ,m, j = 1, 2. We conduct the experiment using one-sided
BT under α = 0.05 and α = 0.1 respectively, then the test statistic for reference
group follow binomial distribution. Here we assume group 1 as reference group,
then Ti ∼ Bin(Xi1 +Xi2, pi), where pi =
λi1
λi1 + λi2
. Set the number of hypotheses
m = {5, 10, 15}, with true null proportion π0 = {0.2, 0.4, 0.6, 0.8} respectively.
For true null hypotheses set the mean parameter of Poisson response in each
group as λ1i = λ2i = 2, and for false null hypotheses set the mean parameter for
group 1 as λ1i = 2, and for group 2 as λ2i = 10. The study and control group
observed individual are chosen randomly from the Binomial distributions.
Using the FET or BET we can calculate the available p-value Pi and all attainable
p-values in the set Pi. Then we compute the simulated FWER, minimal power, number
of rejections by taking average of B = 2000 iterations.
Power = Pr{correctly rejecting at least one null hypotheses}.
Results of the simulation under independence Tables A.1 and A.2 in the
Appendix A show the simulated FWER levels and minimal powers of the compared
four procedures using the FET statistics. First, the proposed Modified Bonferroni
procedure (Procedure 2.1) always has higher FWER level, and more powerful than the
other three procedures. The simulation results also verify that two discrete FWER
controlling procedures (Modified Bonferroni and Tarone) have higher FWER levels
and provide more power than the other two classic procedures (Bonferroni and Sidak).
Second, the FWER levels are less conservative, and the power advantages are larger for
smaller size N , since the data was more discrete for smaller N , then the improvement
is more obvious. For example, when testing m = 10 hypotheses, π0 = 0.2, which
34
implies there are 2 true nulls and 8 false nulls, the simulation result shows that the
FWER improvement of Procedure 2.1 (0.0020) is 300% higher than Tarone procedure
(0.0005) when the simulated data is from binomial with N = 5. But when sample size
N = 125, the improvement is only 35.7% (0.0095 versus 0.0070). Third, as the true
null proportion becomes bigger, the proposed procedures FWER is closer to nominal
significant level 0.05, but power becomes smaller. The power of Procedure 2.1 becomes
larger when testing more hypotheses or using larger sample size N . We also plot the
simulation results in Figures 2.1 and 2.2 for the FWER and minimal power comparisons.




































Methods MBonf Tarone Sidak Bonferroni
Figure 2.1 Simulated FWER comparisons for different single-step procedures based
on FET.
Tables A.3 and A.4 in the appendix show the simulated FWER levels and minimal
powers comparisons using the BET statistics. The results show the proposed Procedure
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Methods MBonf Tarone Sidak Bonferroni
Figure 2.2 Simulated minimal power comparisons for different single-step procedures
based on FET.
2.1 controls FWER and are more powerful than other three procedures under such
settings. For other findings, they are similar to the simulation results based on FET.
2.3.4 Extension for the Proposed Procedures for the Mixed Data Structure
of the Hypotheses
In practice, the hypotheses are commonly involved in a mixed structure for both discrete
and continuous data. then the proposed procedures can be naturally extended as
follows.
Suppose there are m hypotheses H1, . . . , Hm. Let Ic denote the index set of the
hypotheses for continuous data, so the number of continuous test statistics is mc = |Ic|.
The corresponding available p-values under the null one uniformly distributed in [0, 1],
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that is, Fi(p) = p for i ∈ Ic and any p ∈ [0, 1]. Let Id denote the index set of the
hypotheses for discrete data, the number of discrete test statistics is md = |Id| = m−mc
. The corresponding available p-values are stochastically greater than or uniformly
distributed in [0, 1], that is, Fi(p) = p for i ∈ Id and p ∈ Pi; Fi(p) < p for i ∈ Id and
p /∈ Pi. The mixed CDF can be expressed by
Fi(p) = pI{i ∈ Ic}+ Fi(p)I{i ∈ Id}.
Procedure 2.2 (Mixed Bonferroni procedure). Let the critical constant be t =
max{0 ≤ p ≤ 1 : mcp+
∑
i∈Id
Fi(p) ≤ α}, then reject Hi if Pi ≤ t.
Example 2.2. If there are only two hypotheses H1 and H2. The test statistics T1 of
H1 is continuous, then the corresponding p-value P1 ∼ Unif(0, 1). The test statistics
T2 of H2 is discrete, let P2 be the corresponding p-value with atom at 0.01, 0.19, 1 (eg:
T2 ∼ Binomial(2, 0.1), then the CDF of P2 is
F2(p) =

0 0 ≤ p < 0.01
0.01 0.01 ≤ p < 0.19
0.19 0.19 ≤ p < 1
1 p = 1
(2.3.6)
If the significant level α = 0.05, then the critical constant of mixed Bonferroni procedure
is t = max{0 ≤ p ≤ 1 : p + F2(p) ≤ 0.05} = 0.04. While the critical constant for
traditional Bonferroni procedure is t′ = 0.05/2 = 0.025, which is more conservative. If
we observe P1 = 0.03, P2 = 0.01, then only H2 is rejected for Bonferroni procedure, but
H1 and H2 are rejected for mixed Bonferroni procedure.
So the mixed Bonferroni procedure could less conservative than Bonferroni
procedure.
Proposition 2.6 (Adjusted p-value for mixed Bonferroni procedure).









, for i = 1, . . . ,m. (2.3.7)
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Since the mixed Bonferroni procedure is just a special case of Procedure 2.1 only
if some test statistics are continuous, the mixed procedure strongly controls the FWER
under arbitrary dependence and holds all desired properties such as α-consistency, p-
value monotonicity, etc.
2.4 A Step-down Procedure for Discrete Data
By exploiting the discreteness of data, Hommel and Krummenauer (1998) improved
Holm procedure as Procedure 1.4. This procedure could be further improved by utilizing
full sets of p-values.
2.4.1 A New Step-down Procedure
In the last section, we have proposed a new single-step procedure based on the marginal
CDF’s of p-values, and now we develop a more powerful step-down procedure by
exploiting the the same distributional information of null p-values.






F(j)(p) ≤ α} with






if the maximum does not exist. Then
reject no null hypotheses if P(1) > α1; otherwise, reject H(1), . . . , H(r) and retain
H(r+1), . . . , H(m), where r is the largest index satisfying P(1) ≤ α1, . . . , P(r) ≤ αr.
Remark 2.2. It should be noted that when the test statistics have continuous
distributions, which implies Fi ∼ U [0, 1], Fi(p) = p, then




Thus, the procedure reduces to Holm procedure.
Theorem 2.2. Procedure 2.3 strongly controls the FWER at level α under arbitrary
dependence.
Proof. Let I0 be the indices of the true null hypotheses and V denote the number of
falsely rejected hypotheses. If |I0| = 0, then V = 0, FWER = 0 ≤ α is trivial.
When |I0| = m0 ≥ 1, let P̂(1) ≤ · · · ≤ P̂(m0) denote the m0 true null p-values, and
P̌(1) ≤ · · · ≤ P̌(m1) denote the m1 false null p-values.
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Let k be the smallest random index of whole p-values satisfying P(k) = P̂(1), that
is P(k) = min
i∈I0
Pi. It implies P(k), . . . , P(m) include all true null p-values, that is,{



































m− k + 1
, that is, αk =
α
m− k + 1
, by the property of CDF for discrete














m− k + 1
, and if the maximum as definition exists for k − 1, that is,















F(j)(αk−1) ≤ α. If the maximum as definition




m− k + 2
}
. By the similar
argument, FWER ≤ α when αk = αk−1 =
α
m− k + 2
.
By iteration, we can prove until for some l − 1, the maximum exists, then










which completes the proof.
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α-consistency Based on Definition 1.2, we can also explore this desired property for
Procedure 2.3. This property can be proved by using the similar argument in the proof
of Proposition 2.3.
Proposition 2.7. Procedure 2.3 is an α-consistent procedure.
Adjusted p-value We can directly calculate the adjusted p-value of Procedure 2.3
based on the Definition 1.2.8.
Proposition 2.8 (Adjusted p-value for Procedure 2.3).
If P(1) ≤ · · · ≤ P(m) are the available p-value for H(1), . . . , H(m), then the adjusted




















. i = 2, . . . ,m
(2.4.2)
p-value monotonicity According to the calculation of the adjusted p-value Eq.
(2.4.2), we can show that Procedure 2.3 is also p-value monotone using similar argument
of Proposition 2.4.
Proposition 2.9. Procedure 2.3 is p-value monotone.
2.4.2 Applications for Step-down Procedures
cDNA transcripts data We compare the proposed Procedure 2.3 with Holm
procedure and Tarone-Holm Procedure 1.4 using the previous cDNA transcripts
example. We also use their adjusted p-values to make decisions of rejection and
acceptance.
Table 2.3 shows for hypotheses H(1), . . . , H(5), the adjusted p-values of Procedure
2.3 are smaller than those of Holm and Tarone-Holm procedures. That means Procedure
2.3 has more chances to reject H(1), . . . , H(5) than the other two procedures, which
implies our proposed Procedure 2.3 could be more powerful than other two.
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Table 2.3 A Comparison of Adjusted p-values for the Holm Procedure, Tarone-Holm
Procedure and Procedure 2.3 when Testing the Hypotheses in the cDNA Transcript
Example from Hommel and Krummenauer (1998)
(i) X0i/N0i X1i/N1i P(i) P̃(i),Holm P̃(i),TH∗ P̃(i),MHolm
(1) 1/10 8/11 0.0058 0.0552 0.0116 0.0097
(2) 0/8 5/7 0.0070 0.0559 0.0140 0.0109
(3) 0/11 4/10 0.0351 0.2456 0.1404 0.1072
(4) 1/11 3/9 0.2167 1.0000 1.0000 0.4268
(5) 2/11 4/10 0.2678 1.0000 1.0000 0.6347
(6) 1/10 3/10 0.2910 1.0000 1.0000 1.0000
(7) 2/9 2/8 0.6647 1.0000 1.0000 1.0000
(8) 2/9 2/9 0.7118 1.0000 1.0000 1.0000
(9) 2/9 2/9 0.7118 1.0000 1.0000 1.0000
Clinical safety data We also compare these step-down procedures using the previous
clinical safety data example.
Table 2.4 A Comparison of Adjusted p-values for the Holm Procedure, Procedure 1.4
and Procedure 2.3 when Testing the Hypotheses for AE Types of Body System 10 in
the Clinical Safety Data Example from Mehrotra and Heyse (2004), where the Numbers
of Patients for Two Groups are N1 = 148 and N2 = 132
(i) X1i X2i P(i) P̃(i),Holm P̃(i),TH∗ P̃(i),MHolm
(1) 13 3 0.0209 0.1880 0.0836 0.0534
(2) 8 1 0.0388 0.3103 0.1163 0.0982
(3) 4 0 0.1248 0.8734 0.6238 0.5050
(4) 0 2 0.2214 1.0000 1.0000 1.0000
(5) 6 2 0.2885 1.0000 1.0000 1.0000
(6) 2 0 0.4998 1.0000 1.0000 1.0000
(7) 1 2 0.6033 1.0000 1.0000 1.0000
(8) 4 2 0.6872 1.0000 1.0000 1.0000
(9) 2 1 1.0000 1.0000 1.0000 1.0000
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Table 2.4 shows for hypotheses H(1), . . . , H(3), the adjusted p-values of Procedure
2.3 are smaller than those of Holm and Tarone-Holm procedures. It means Procedure
2.3 has more chances to reject H(1), . . . , H(3) than the other two procedures, which
implies our proposed Procedure 2.3 could be more powerful than other two.
2.4.3 Simulation Study for Step-down Procedures Comparisons
In this section, simulation studies were performed to investigate the performances of
the proposed Procedure 2.3 in terms of the FWER level and minimal power compared
with two existing step-down procedures: Holm procedure and Tarone-Holm procedure
in Hommel and Krummenauer (1998). The step-down procedures simulations are
conducted by using Fisher’s Exact Test only, since using binomial exact test produces
similar patterns. The same simulation settings in Section 2.3.3 are used for this
comparison. The simulations results are shown in the Tables A.5 and A.6 in the
Appendix A.
The results show that Procedure 2.3 always controls FWER and are more powerful
than other procedures. Moreover, by comparing the results in the Tables A.1 and
A.2, the proposed step-down Procedure 2.3 is more powerful than proposed single-step
Procedure 2.1. We also plot the simulation results in Figures 2.3 and 2.4 for the FWER
and minimal power comparisons.
2.5 A Step-up Procedure for Discrete Data
2.5.1 A New Step-up Procedure
By using the same critical constants of Procedure 2.3, we can develop a new step-up
procedure for discrete data.






F(j)(p) ≤ α} with






if the maximum does not exist. Then reject
all hypotheses H(1), . . . , H(m) if P(m) ≤ αm; otherwise, reject H(1), . . . , H(r) and retain
H(r+1), . . . , H(m), where r is the largest index satisfying P(r) ≤ αr.
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Methods MHolm Tarone−Holm Holm
Figure 2.3 Simulated FWER comparisons for different step-down procedures based
on FET.
Remark 2.3. It should be noted that when the true null test statistics have continuous
distributions, which implies that all true null p-values are uniformly distributed in [0, 1],
the above procedure will reduce to conventional Hochberg procedure.
Theorem 2.3. If the true null test statistics are identically distributed, (i) then
Procedure 2.4 strongly controls the FWER at level α under the Assumption 1.2.
(ii) Moreover, the Procedure 2.4 rejects the same number of hypotheses as Hochberg
procedure.
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Methods MHolm Tarone−Holm Holm
Figure 2.4 Simulated minimal power comparisons for different step-down procedures
based on FET.
Proof. Since the test statistics have the same distribution, then true null p-values have
the same domain P and CDF F (·), then for each i,







= max{p ∈ P : (m− i+ 1)F (p) ≤ α}
= max
{









Procedure 2.4 also controls the FWER since Hochberg procedure controls the FWER.
To prove (ii), let R = max{i : P(i) ≤
α
m− i+ 1
} be the number of rejections using
Hochberg procedure, then the critical p-value P(R) of the Hochberg procedure can be
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written as
P(R) = max{P(i) : P(i) ≤
α
m− i+ 1




which is the critical value αR of Procedure 2.4. That is, Procedure 2.4 has the same
number of rejections as Hochberg procedure.
Theorem 2.4. If the true null p-values only take two attainable values between 0 and
1, then Procedure 2.4 controls the FWER under arbitrary dependence.
Proof. Since the true null p-values only take two attainable values between 0 and 1, the
domain of each p-value is
Pi = {pi, 1}, where 0 < pi < 1.
Suppose there are only two hypotheses H1 and H2, the corresponding available p-values
are P1 and P2, where P1 ∈ {p1, 1} and P2 ∈ {p2, 1}. Without loss of generality, assume




α/2, α < p1
p1, p1 ≤ α < p1 + p2
p2, p1 + p2 ≤ α ≤ 1
and
α2 =
α, α < p2p2, p2 ≤ α ≥ 1.
There are three cases containing rejections based on the values of attainable p-
values.
Case 1: If P1 = p1, P2 = 1, since P2 = 1 > α2, accept H2. To reject H1, one need
to check P1 ≤ α1 if and only if p1 ≤ α. Case 2: If P1 = 1, P2 = p2, similarly, accept
H1. To reject H2, one need to check P2 ≤ α1 if and only if p1 + p2 ≤ α. Case 3: If
P1 = p1, P2 = p2, only need to check whether P1 ≤ α1 to ensure at least one rejection.
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Then the maximum FWER is
FWERmax = Pr(P1 = p1, P2 = 1) + Pr(P1 = p1, P2 = p2) + Pr(P1 = 1, P2 = p2)
≤ Pr(P1 = p1) + Pr(P2 = p2)
= p1 + p2 ≤ α,
which completes the proof.
This step-up procedure has similar properties as those of Procedure 2.1 and
Procedure 2.3 such as α-consistency and p-value monotonicity. But it provides a higher
power, since a step-up procedure is uniformly more powerful than the corresponding
step-down procedure using the same threshold. Real data analysis and simulation
studies also show this procedure outperforms the others.
α-consistency Procedure 2.4 is an α-consistent procedure, since the critical values
of these procedures are non-decreasing in α. So we have the following propositions:
Proposition 2.10. Procedure 2.4 is an α-consistent procedure.
Adjusted p-value The adjusted p-value of Procedure 2.4 can be obtained based on
Definition 1.2.8.
Proposition 2.11 (Adjusted p-value for Procedure 2.4).
If P(1) ≤ · · · ≤ P(m) are the available p-value for H(1), . . . , H(m), then the adjusted
p-value P̃(i),MHoch for corresponding hypothesis H(i) is
P̃(i),MHoch =









. i = m− 1, . . . , 1
p-value monotonicity Similar as previous argument in Proposition 2.4, we can show
that Procedure 2.4 are p-value monotone.
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2.5.2 Applications for Step-up Procedures
cDNA transcripts We also compare the proposed step-up Procedure 2.4 with
traditional Hochberg procedure using the previous cDNA transcripts example. We
also use their adjusted p-values to make decisions. The results are shown in Table 2.5.
Table 2.5 A Comparison of Adjusted p-values for the Hochberg Procedure, Procedure
1.5 and Procedure 2.4 when Testing the Hypotheses in the cDNA Transcript Example
from Hommel and Krummenauer (1998)
(i) X0i/N0i X1i/N1i P(i) P̃(i),Hochberg P̃(i),Roth P̃(i),MHoch
(1) 1/10 8/11 0.0058 0.0552 0.0117 0.0097
(2) 0/8 5/7 0.0070 0.0559 0.0140 0.0109
(3) 0/11 4/10 0.0351 0.2456 0.1765 0.0944
(4) 1/11 3/9 0.2167 0.7118 0.7118 0.4268
(5) 2/11 4/10 0.2678 0.7118 0.7118 0.6347
(6) 1/10 3/10 0.2910 0.7118 0.7118 0.7118
(7) 2/9 2/8 0.6647 0.7118 0.7118 0.7118
(8) 2/9 2/9 0.7118 0.7118 0.7118 0.7118
(9) 2/9 2/9 0.7118 0.7118 0.7118 0.7118
The results in Table 2.5 show that for hypotheses H(1), . . . , H(5), the adjusted
p-values of Procedure 2.4 are smaller than those of Hochberg and Roth procedure.
It means Procedure 2.4 has more chances to reject H(1), . . . , H(5) than Hochberg and
Roth procedure, which implies our proposed Procedure 2.4 could be more powerful than
Hochberg procedure.
Clinical safety data We also compare these step-up procedures using the previous
clinical safety data example.
Table 2.6 shows for each AE with the hypotheses H(1), . . . , H(3), the adjusted
p-values of Procedure 2.3 are smaller than those of Holm and Tarone-Holm procedures.
It means Procedure 2.3 has more chances to reject H(1), . . . , H(3) than the other two
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Table 2.6 A Comparison of Adjusted p-values for the Hochberg Procedure, Procedure
1.5 and Procedure 2.4 when Testing the Hypotheses for AE types of Body System 10 in
the Clinical Safety Data Example from Mehrotra and Heyse (2004), where the Numbers
of Patients for Two Groups Are N1 = 148 and N2 = 132
(i) X1i X2i P(i) P̃(i),Hochberg P̃(i),Roth P̃(i),MHoch
(1) 13 3 0.0209 0.1880 0.0836 0.0534
(2) 8 1 0.0388 0.3103 0.1552 0.0982
(3) 4 0 0.1248 0.8734 0.7246 0.5050
(4) 0 2 0.2214 1.0000 1.0000 1.0000
(5) 6 2 0.2885 1.0000 1.0000 1.0000
(6) 2 0 0.4998 1.0000 1.0000 1.0000
(7) 1 2 0.6033 1.0000 1.0000 1.0000
(8) 4 2 0.6872 1.0000 1.0000 1.0000
(9) 2 1 1.0000 1.0000 1.0000 1.0000
procedures, which implies our proposed Procedure 2.3 could be more powerful than
other two.
2.5.3 Simulation Studies for Step-up Procedures Comparisons
We now present simulation studies comparing the new step-up FWER controlling
procedure (Proc 2.4) with Hochberg procedure. We only show the simulations based on
Fisher’s Exact Test, since simulations using Binomial Exact Test have similar patterns.
The results of comparisons are shown in Tables A.7 and A.8. The results show
that Procedure 2.4 controls FWER and is universally more powerful than Hochberg
Procedure. We also plot the simulation results in Figures 2.5 and 2.6 for the FWER
and minimal power comparisons
2.5.4 Simulation Studies for the Dependence Settings
We have performed the simulation studies for stepwise FWER controlling procedures
when p-values are independent. Now we focus on the dependence case. Since it is
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Methods MHoch Roth Hochberg
Figure 2.5 Simulated FWER comparisons for different step-up procedures based on
FET.
not easy to construct an arbitrary dependence structure for discrete test statistics, we
construct a special blocking dependence for the simulation.
Let Poi(λ) denote the Poisson distribution with mean λ, Bin(n, p) denote the
binomial distribution with probability of success p and number of trials n. For the BET,
let x1i and x2i be the observed counts from two independent Poisson distributions with
mean λ1i and λ2i, where i = 1, . . . ,m. Then test Hi : λ1i = λ2i versus H
′
i : λ1i < λ2i,
where i = 1, . . . ,m. The test statistic Ti for each i is based on the total ci = x1i + x2i
is Bin(ci, θi), where θi = λ1i/(λ1i + λ2i). (Lehman and Romano, 2005) Then, under
the null hypothesis Hi : λ1i = λ2i, Ti follows binomial distribution Bin(ci, 0.5) and its
distribution only depends on ci. Then the following simulations are conducted based
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Methods MHoch Roth Hochberg
Figure 2.6 Simulated minimal power comparisons for different step-up procedures
based on FET.
on dependent binomial exact test (BET) statistics. The details for generating the
dependent simulation data can be found in Appendix A.
In the simulation, set the number of hypotheses m = {5, 10}, with true null
proportion π0 = {0.4, 0.6, 0.8} respectively. Set the mean parameter of Poisson response
in each group as λ1i = λ2i = 2 for i = 1, . . . ,m0, and set the mean parameter for group
1 as λ1i = 2, and for group 2 as λ2i = 10 for i = m0 +1, . . . ,m , where m0 = π0m. Then
compute the simulated FWER, minimal power to compare the different procedures by
taking average of B = 2000 iterations.
Remark 2.4. Note that the above simulated p-values have joint dependence within the
group of true null hypotheses, but the p-values corresponding to true null hypotheses
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are independent of the false ones, which is the same as condition (3.5) in Romano and
Shaikh [58]. This setting also satisfies PRDS condition.
The simulation results comparisons for stepwise procedures (single-step, step-
down, and step-up) are displayed in Figures 2.7 to 2.12. More simulation results for


































Methods MBonf Tarone Sidak Bonferroni
Figure 2.7 Simulated FWER comparisons for different single-step procedures based
on the blocking dependent BET.
From the simulation results, we can see Procedure 2.1, 2.3 and 2.4 control FWER
under the significant level α = 0.05. Under different settings of the correlation






































Methods MBonf Tarone Sidak Bonferroni
Figure 2.8 Simulated minimal power comparisons for different single-step procedures
based on the blocking dependent BET.
Bonferroni procedures, Modified Holm procedure is more powerful than Tarone-Holm
and Holm procedures, and Modified Hochberg procedure is more powerful than Roth’s
and Hochberg procedures.
2.6 Conclusions and Discussion
In this chapter, we have developed several FWER controlling procedures for discrete
data by exploiting the information of discreteness for test statistics. The proposed






































Methods MHolm Tarone−Holm Holm
Figure 2.9 Simulated FWER comparisons for different step-down procedures based
on the blocking dependent BET.
2.4 controls FWER under PRDS condition for some specific distributions settings.
Real data analysis in both clinical safety studies and cDNA transcript data reveals
that the proposed procedures have more rejections than conventional procedures. The
simulation studies show that when the proportion of true null hypotheses is large,
which is usually the case in practical applications, the proposed stepwise procedures
can outperform the corresponding Bonferroni, Holm and Hochberg procedures and
even better than some existing discrete procedures, such as Tarone and Tarone-Holm






































Methods MHolm Tarone−Holm Holm
Figure 2.10 Simulated minimal power comparisons for different step-down procedures
based on the blocking dependent BET.
A possible future work is to explore optimality of the suggested Procedure 2.1
and 2.3 under arbitrary dependence, which means for some joint distribution of the
discrete p-values, one cannot increase even one of the critical constants while keeping
the remaining fixed without losing control of the FWER. Another possible future work
is to incorporate some data driven weights into the proposed procedures to develop






































Methods MHoch Roth Hochberg
Figure 2.11 Simulated FWER comparisons for different step-up procedures based on
the blocking dependent BET.
2.7 Software
The FWER controlling procedures for discrete data described in this chapter have
been implemented as a part of the MHTdiscrete R package [Zhu and Guo, 2017], which
is available online at https://cran.r-project.org/web/packages/MHTdiscrete. A web
application for the proposed procedures and most existing FWER and FDR controlling






































Methods MHoch Roth Hochberg
Figure 2.12 Simulated minimal power comparisons for different step-up procedures
based on the blocking dependent BET.
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CHAPTER 3
SELECTIVE INFERENCE IN CLINICAL SAFETY STUDIES
3.1 Introduction
In clinical safety studies, there are many adverse events (AE) recorded in one clinical
trial. The goal for assessing the safety of an experimental drug is to flag “reasonable” or
“correct” AEs among these AE types. Chen et al. (2015) [13] summarized most existing
signal detection methods, such as proportional reporting ratios [19], reporting odds
ratios [60], and the maximum likelihood ratio test [41], Bayesian confidence propagation
neural network method [2] and multi-item Gamma Poisson shrinker [66] for spontaneous
reporting data, and Pearsons chi-square test, Fishers exact test, and the chi-square test
for rates comparison for flagging safety signal in clinical trials. The above detecting
or flagging methods do not control for overall type 1 error rates, such as FWER or
FDR. In fact, the number of possible AEs is usually very large (see TCTAE v4.03 and
MedDRA
R©
v19.1). Thus, similar as dealing with multiple endpoints in drug efficacy
analysis, multiplicity effect should be also considered in drug safety analysis. However,
the number of AEs in safety analysis is much larger than the number of endpoints in
efficacy analysis for the experimental drugs. Therefore, FWER controlling procedures
such as Bonferroni procedure may fail to flag more important AEs. Benjamini and
Hochberg (1995) introduced the concepts of false discovery rate (FDR), which is defined
as the expected proportion of the false rejections among all discoveries. Their proposed
BH step-up procedure becomes the most popular multiple testing procedure (MTP) for
the large-scale multiple hypotheses testing in the last two decades. The BH procedure
can be applied to detect the signals of the AEs, since the number of AEs in clinical
safety studies is usually large.
Searching for significant AEs, the AE types (Preferred Term (PT) in MedDRA
R©
)




). Each AE can be regarded as a hypothesis, and the hypotheses of AEs from
the same body system naturally forms a family. So the multiple-family structure should
be considered for the drug safety data analysis. Recently, some structured BH-type
procedures are developed for multiple families of hypotheses (Mehrotra and Heyes,
2004; Mehrotra and Adewale, 2012; Hu et al., 2010; Benjamini and Bogomolov, 2014).
Mehrotra and Heyes (2004) proposed a two-stage double FDR (DFDR) procedure,
which firstly uses BH procedure on the minimum original p-values of each family under
level α1, then applies the BH procedure on the hypotheses in the selected families under
level α. The problem is this procedure cannot guarantee FDR control. It is also not
clear for how to choose the significant level α1 in the first step. Mehrotra and Adewale
(2012) modified the DFDR procedure by using BH procedure in the first step on the
minimum BH-adjusted p-value under the same significant level α as the second step.
The DFDR2 procedure still cannot guarantee FDR control. The main reason is the
procedure does not consider the selection effect for the first step. Other recent references
also examined related questions for multiple-family multiple hypotheses testing. Hu et
al. (2010) introduced a p-value weighting group BH procedure (GBH) by estimating the
true null proportion for each group, the method asymptotically controls global FDR.
Benjamini and Bogomolov (2014) provides a general framework for multiple families
multiple testing considering selection effect, and defined average FDR and average
FWER over the selected families as desired type 1 error rates. Their proposed procedure
(BB) can guarantee the average FDR control. Actually, the DFDR2 procedure and
original BB procedure select the same families by using the same selection rule in the
first step, the main difference between these two procedures is original BB procedure
uses Rα/m to conduct individual test in each selected family. Barber and Ramdas
(2016) proposed a multilayer FDR controlling procedure, which can guarantee FDR
control on family level and control global FDR, but they do not consider any error
rate control within selected families. The above methods do not clearly separate the
selection effect and multiplicity effect. To overcome this problem, selective inference
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by using conditional inference such as conditional type 1 error rate control, selection
adjusted confidence interval is developed recently (Fithian et al., 2015; Weinstein et al.,
2013; Heller et al., 2016).
In practice, especially in clinical safety studies, we may not only need to flag the
AE, but also want to investigate the body systems for the further research (Berry and
Berry, 2004). For example, if some body systems are selected, but there is no AE
flagged in these selected body systems, we can also use the body system information
to conduct follow-up studies. Thus controlling some type 1 error in family level is also
necessary. Since the number of body systems is not very large (commonly 5-50), and
sometimes we may allow more than one type 1 errors made when doing selection. Thus,
the generalized familywise error rate (k-FWER) is a suitable error measure in practice,
which is the probability of making at least k false rejections. Some existing k-FWER
controlling procedure include Lehmann and Romano (2005), Guo and Romano (2007),
Sarkar (2006, 2007). And this selection rule using k-FWER controlling procedure is
also a simple selection rule. We can conclude some similar conclusions for selective
inference within the selected families as Benjamini and Bogomolov (2014) and Heller
et al. (2016).
So far, there are growing literature of approaches for testing multiple hypotheses
with multiple families structure. But very few valid methods were used in clinical safety
adverse events. So this chapter aims to develop a selective inference-based two-stage
procedure in the settings of clinical safety studies. We consider using combining
methods on the conditional p-values, as described in the preliminaries in Section 3.2.
Some existing multiple testing procedures for multiple families are introduced for clinical
safety settings as well. The valid two-stage procedure is proposed in Section 3.3.
Theoretical results of our proposed procedures are provided in Section 3.4. Then we
discuss the selection rules effect in Section 3.5. In Section 3.6, simulation studies are
also conducted to compare the proposed procedure with other existing procedures and
compared the proposed procedure for different selection rules regarding choices for
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combining methods and generalized FWER fold k. Section 3.7 explores several clinical
safety examples to illustrate the proposed procedure and compare the outcomes with
other existing multiple families multiple testing procedures. Some concluding remarks
are made in Section 3.8 and one R package “MHTmult” is implemented in Section 3.9.
Proofs of some results are given in the Appendix B.
3.2 Preliminaries
In this section, some necessary notations and basic concepts are introduced. In clinical
safety studies, several body systems contain amount of AE types, the body systems
are regarded as multiple families, AE types classified by body systems forms individual
hypotheses. Therefore, flagging significant AE in some body systems can be formulated
as a multiple testing problem with hierarchical multiple families structure.
3.2.1 Notations
Suppose that there are n =
m∑
i=1
ni AE types, denoted by AEij, i = 1, . . . ,m, j =
1, . . . , ni, appearing in m body systems denoted by BS1, . . . , BSm. The hypotheses Hij
to flag AEij are to be simultaneously tested based on their corresponding p-values Pij,
i = 1, . . . ,m, j = 1, . . . , ni. Let H̃i be the global null hypothesis for i-th body system,
that is, H̃i =
ni⋂
j=1
Hij. The global hypothesis is true only if all Hij in this body system are
true. Let P̃i denote the p-value of the corresponding global hypothesis H̃i.We use the
global test to select body systems. Let S denote the index set of selected hypotheses,
that is, S = {i : H̃i is rejected}
Assume individual p-values are stochastically greater than Uniform(0,1), that is,
Pij satisfies
Pr{Pij ≤ t} ≤ t, for t ∈ (0, 1), (3.2.1)
then the global p-value P̃i satisfies
Pr{P̃i ≤ t̃} ≤ t̃, for t̃ ∈ (0, 1). (3.2.2)
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3.2.2 Several Type 1 Error Rates
The most commonly used type 1 error rates are familywise error rate (FWER) and false
discovery rate (FDR), which are defined in Chapter 1. Here we specifically introduce
some type 1 error rates for multiple families structure.
Type 1 error rate for family level In the clinical safety studies, the number of
body systems is often moderate (5-50). Based on the requirement of future research,
the error measurement is usually not as strict as allowing to make only one type I
error (falsely selecting one body system). Sometimes, the clinical studies would like
to control the probability of falsely selecting at least k body systems under 5%-10%,
where 1 ≤ k ≤ m. Thus when selecting body systems of interest (BSoI), controlling
the generalized FWER for body system level is desired. Let Ṽ denote the number of
false selections when selecting BSoI using global p-values, then generalized FWER is
defined as
k-FWER = Pr(Ṽ ≥ k)
If k = 1, k-FWER will become FWER. The commonly used k-FWER procedures are
generalized Bonferroni and generalized Sidak procedure.







t̃l(1− t̃)m−l = α1.
Type 1 error rate for individual level Considering the selection effect, it is valid
to use conditional inference for flagging AEs in testing step. Then define the FWER
and FDR measures conditional on the selected BSoI as follows.
Let Vi denote the number of false rejections for i-th body system, and Ri denote
the number of total rejections for i-th family. Then the conditional FWER selected
i-th family is defined as
cFWERi = Pr(Vi > 0|i ∈ S) = E{I(Vi > 0)|i ∈ S},
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∣∣∣i ∈ S} .
The advantage of conditional error measure is it can distinguish the selection
effect introduced in the first stage from the multiplicity effect in the second stage. We
can use this information to develop more powerful procedure than existing procedure.
In practice, t is preferred to control cFDR for flagging AE within the selected body
systems in clinical safety studies, since the number of AEs is very large, cFWER control
is too strict.
Overall type 1 error rate An overall error measure addressing selective inference









which is expected average of false rejection proportions across selected families.
Another overall error measure is global FDR, which is used in several references









Remark 3.1. We can observe if the numbers of total rejections are the same, the
average-FDR and global-FDR are equivalent. Otherwise, these two overall FDR
measures are different. The procedures considering average FDR control often give
up the global FDR control (Benjamini and Bogomolov (2014)). It makes more sense
to consider average FDR control if the selected families are heterogeneous, such as
the body systems in clinical safety studies are functionally different regarding the AE
response for the experimental drugs.
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3.2.3 Several Existing Two-stage Multiple Testing Procedures
The original double FDR (DFDR) procedure and modified double FDR (DFDR2)
procedure are proposed in clinical safety settings, but original Benjamini and Bogomolov
(BB) procedure and its modification are proposed in GWAS settings, which are much
larger scale settings.
The original double FDR (DFDR) procedure proposed by Mehrotra and Heyse
(2004) is described as follows.
Procedure 3.2 (DFDR).
Step 1: (a) For each body system, find the minimum p-value p̃i = min
1≤j≤ni
{pij}.
(b) Apply BH procedure on p̃1, . . . , p̃m at level α1 to select BSoI.
Step 2: In the i-th selected body system, apply BH procedure on pi1, . . . , pini at level α
to flag AEs.
Note that the minimum p-values p̃i are not uniformly distributed any more, so
the BH procedure applying on those minimum p-values cannot strongly control FDR.
The modified double FDR (DFDR2) procedure developed by Mehrotra and Adewale
(2012) replaces the minimum p-value by minimum BH-adjusted p-value for each body
system.
Procedure 3.3 (DFDR2).




(b) Apply BH procedure on p̃1, . . . , p̃m at level α to select BSoI.
Step 2: In the i-th selected body system, apply BH procedure on pi1, . . . , pini at level α
to flag AEs.
However, since it still uses α as in Step 2, which brings selection bias in testing
step. Then the DFDR2 still cannot control average FDR or global FDR under α.
In R software, use p.adjust() function to compute the BH-adjusted p-values within
each body system, and find the minimum one. Note that the minimum BH-adjusted
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pi(j)}, which is a valid global
p-value uniformly distributed in [0,1].
Benjamini and Bogomolov (2014) recommended to use the BH procedure on the
set of minimum BH-adjusted p-values as a simple selection rule, then in each selected
family apply BH procedure at an selection-adjusted level which is less than the nominal
significant level, and determined by number of selected families.
Procedure 3.4 (Original BB: BB-α-BH-α).




(b) Apply BH procedure on p̃1, . . . , p̃m at level α to select BSoI.
Step 2: (a) Count the number of selected body systems as |S|.
(b) In the i-th selected body system, apply BH procedure on pi1, . . . , pini at level
|S|
m
α to flag AEs.
It can be seen that the original BB procedure proceeds the same selecting step
(Step 1) as DFDR2 procedure, the only difference is in testing step (Step 2), original
BB procedure uses a adjusted significant level |S|
m
α, which is smaller than α.
Peterson et al. (2016) modified the original BB procedure (BB-α-BH-α1), which
applies BH procedure at level α1 to select BSoI. The selection level α1 is not necessarily
equal to testing level α.
Although original BB procedure and its modification guarantee average FDR
control, they both select body systems using BH procedure, which is too liberal for
moderate number of body systems in clinical safety studies.
Procedure 3.5 (Group BH-TST estimation).
Step 1: (a) For each body system, using Benjamini et al. (2006) two-stage estimator,
compute the estimated true null proportion π̂0i = n̂0i/ni for i-th body
system.












(b) Pool the weighted p-value together as pw1 , . . . , p
w
n , then apply BH procedure
on the pooled p-values at level
α
(1 + α)(1− π̂0)
to flag AEs.
3.2.4 Combining Functions and Conditional p-values
Since we are dealing with a selected family of hypotheses based on the global test, we
will omit the index i for family to simplify the notation. Also use n replace ni to denote
the number of hypothesis within a family.
Let f : Rn → R be a combining function for testing the global null on each
family. Here we require f is a monotone function of each pj. Let t denote the fixed
hypothesis/family selection threshold, i.e. f(P1, . . . , Pn) ≥ t for non-increasing f or
f(P1, . . . , Pn) ≤ t for non-decreasing f . Let bj be an inflation factor to determine
the conditional p-value p′j satisfying f(p
(−j), bj) = t for bj ∈ (0, 1], where p(−j) =
p1, . . . , pj−1, pj+1, . . . , pn. Then we can define conditional p-value as
P ′j := Pj|f(p(−j), Pj) ≤ t =
Pj
bj
The following are three typical examples for calculating inflation factor and
conditional p-values using Fisher’s, Stouffer’s and Tippet’s combining methods.
For Fisher’s combining method, the family will be selected if and only if the
p-values of this family satisfy −2
n∑
j=1
log pj ≥ t, which implies pj
n∏
l=1(6=j)
pl ≤ e−t/2, then



























For Stouffer’s combining method, the family will be selected if and only if the
















nt. Then within the selected family, the inflation factor of


















For Tippet’s (minP) combining method, the family will be selected if and only if
the p-values of this family satisfy min{p1, . . . , pn} ≤ t, that is, min{pj,p(−j)} ≤ t. So
we call this method as minP combining method. Then within the selected family, the
inflation factor of pj will be
bj =

t if min{p(−j)} > t
1 otherwise.





if min{p(−j)} > t
pj otherwise.
Remark 3.2. If there is only one hypothesis with the p-value P in selected family,
the conditional p-value follows Pr{P ≤ p|P ≤ t} = p/t for any t > p. According to
the inflation factor b satisfies b = t, the conditional p-value will be p′ = p/b = p/t.
Similarly, for Fisher’s combining method, the inflation factor b satisfies −2 log b = t,
then b = e−t/2, so the conditional p-value is p′ = p/e−t/2. For Stouffer’s combining
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method, the inflation factor b has to satisfy
Φ−1(1− b)√
n
= t, then b = 1 − Φ(t), so the




3.3 A Valid cFDR Controlling Procedure Using k-FWER Controlling
Selection Rule
When we conduct the two-stage procedure, the first stage (selecting step) selects
some significant body systems based on the global null p-values P̃1, . . . , P̃m. Let
S ⊆ {1, . . . ,m} denote the set of selected body systems. Selecting body systems could
be controlled for generalized familywise error rate (denoted by k-FWER) with k ≥ 1
folds under α level. A simple example is to consider generalized Bonferroni procedure
selection rule, then S = {i : P̃i ≤ kαm }.
The second stage (testing step) simultaneously tests the individual hypotheses in
the selected body systems based on the individual p-values Pij, i ∈ S, j = 1, . . . , ni, to
flag significant AEs, which is the final goal for the safety studies. Since testing individual
hypothesis is conditional on their body systems being selected, the procedure could
guarantee conditional FDR control. The two-stage selective inference-based procedure
is described as follows.
Procedure 3.6 (cFDR-α-minP-k-Sidak-α1).
Step 1: (a) For each body system, compute the global p-value p̃i = ni min
1≤j≤ni
{pij}.
(b) Apply generalized Sidak procedure on p̃1, . . . , p̃m at level α1 to select body








t̃l(1− t̃)m−l = α1.






{pis} > ti; otherwise, p′ij = pij, where ti = t̃ni .
(b) Apply BH procedure on p′i1, . . . , p
′
ini
at level α to flag AEs.
Remark 3.3. The selection rule: p̃i ≤ t̃ is equivalent to minP combining function




Remark 3.4. A modified BB procedure using the same minP combining k-FWER
controlling selection rule as Procedure 3.6 can be naturally developed. That is, the
procedure uses Step 1 of the Procedure 3.6 to select body systems, and Step 2 of the
Procedure 3.4 to flag AEs (BB-α-minP-k-Sidak-α1). Such a procedure still uses a simple
selection rule, so it strongly controls average FDR as the Theorem 1 in Benjamini and
Bogomolov (2014) stated. We compare this modified BB procedure using the same
selection rule as the proposed procedure in the simulation studies.
3.4 Theoretical Results
Since conditional p-values can be easily obtained using the above combination methods,
it is natural to conduct MTPs for individual hypothesis (AE type) in the selected
families (BSoI). The followings are some theoretical results for the two-stage procedure
controlling conditional FDR within the selected families. Theorem 3.1, Lemma 3.1 and
Theorem 3.2 still omit the index i for family to simplify the notation. Also use identical
number of hypothesis within each family n replace ni.
Theorem 3.1 (Fisher’s combining selection rule). Let P1, . . . , Pn be independent
p-values with U(0, 1) under true null. If
f(p1, . . . , pn) = −2
n∑
j=1
log pj ≥ t, then the BH procedure on conditional p-values
p′1, . . . , p
′




Some desired properties for conditional p-values can be found.
Note that for Fisher’s combing method, we have the following desired statistical
property of the conditional p-values.
Lemma 3.1 (conditional p-value monotonicity). For Fisher’s combining function, if
the unconditional p-value p1 ≤ · · · ≤ pn, then the conditional p-value p′1 ≤ · · · ≤ p′n.
Remark 3.5. Note that the conditional p-values using minP selection rule does not
always satisfy monotone property. Here is a counterexample: suppose use minP
selection rule with t = 0.05 to select two hypotheses p1 = 0.04 ≤ p2 = 0.06, Since
p2 > t, p
′
1 = p1/t = 0.8. Since p1 ≤ t, p′2 = p2 = 0.06. So p′1 > p′2.
Remark 3.6. For minP combining method, based on the assumption min{p1, . . . , pn} ≤
t, at least one inflation factor should be 1, which means at least one hypothesis will not
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be inflated. The fewer inflated p-values, the smaller selective effect the MTP produces.
Actually, for minP combing method, except for the minimum p-value, other p-values
do not need to be inflated.
For minP combining method, the conditional FDR can also be controlled under
α level.
Theorem 3.2 (minP combining selection rule). Let P1, . . . , Pn be independent p-values
with U(0, 1) under true null. If f(p1, . . . , pn) = min{p1, . . . , pn} ≤ t and α ≤ t ≤ 1,
then the BH procedure on conditional p-values p′1, . . . , p
′




Note that the threshold t is the same as the ti =
t̃
ni
in Procedure 3.6. In Procedure
3.6, p̃i = ni min
1≤j≤ni
{pij} ≤ t̃ is equivalent to min
1≤j≤ni







tl(1− t)m−l = α1. Since 1− (1− t)1/ni can be regarded as a fixed threshold for
each body system i, thus we have the following result.
Theorem 3.3 (cFDR control). For each selected body system Fi, if individual p-values
Pi1, . . . , Pini are mutually independent with U(0, 1) under true null, then Procedure 3.6
strongly controls the conditional FDR at level α for flagging AEs within the selected
body systems.
Now we have the following result for selecting families.
Theorem 3.4 (k-FWER control). If global p-values P̃1, . . . , P̃m are mutually independent
with U(0, 1) under true null, then Procedure 3.6 strongly controls the k-FWER at level
α1 across body systems.
This theorem follows from the proof of Theorem 2.2 in Guo and Romano (2007).
Corollary 3.1 (average FDR control). Under the independence assumption of Theorem
3.3 and 3.4, Procedure 3.6 strongly controls the average FDR over selected body systems
at level α for flagging AEs.
Theorem 3.3, Theorem 3.4 and Corollary 3.1 imply the proposed procedure can
strongly control various type 1 error rates for selecting body systems (k-FWER),
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flagging AE within each selected body system (condition FDR) and overall flagging
AEs average on all selected body systems (average FDR). Next we will look into how
the selections rules affect the proposed procedure.
3.5 Selection Rule Comparisons
As illustrated in Procedure 3.6, using a multiple testing procedure (MTP) on the
combined p-values (global p-values), and selecting the families accordingly, is a natural
approach in selective inference. In the following, we will compare some different
selection rules regarding p-value combining methods and selection procedures.
We start from a simple example. Suppose we have selected a family of n = 2
hypotheses, since conditional p-value is based on inflation factor, which is relevant to
other p-values and selection cutoff, we want to look into how the other p-values and
selection cutoff affect inflation factor under the examples iin the Section 3.2.4.
3.5.1 Inflation Factor
Firstly, for Fisher’s combining function, suppose the family will be selected if and only if
−2(log p1 +log p2) > tF , that is, p1p2 ≤ e−tF /2. Within the selected family, the inflation





if p2 > e
−tF /2
1 otherwise.
Figure 3.1 is to show b1 versus p2, set t = {0, 1, . . . , 10}; Figure 3.2 is to show b1
versus t, set p2 = {0, 0.02, 0.04, 0.06, 0.1, . . . , 1}.
For Stouffer’s combining function, suppose the family will be selected if and only













Figure 3.3 is to show b1 versus p2, set t = {−3,−2.5, . . . , 3}; the second plot of
Figure 3.4 is to show b1 versus t, set p2 = {0, 0.1, 0.2, . . . , 1}.
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inflation factor versus the other p−value 









. . . . . .
t=10
Figure 3.1 Comparison of inflation factor b1 with respect to p2 for different values of
threshold t using Fisher’s combining method with n = 2 hypotheses.













inflation factor versus selection cutoff 






. . . . . .
p2=1
Figure 3.2 Comparison of inflation factor b1 with respect to threshold t for different
values of p2 using Fisher’s combining method with n = 2 hypotheses.
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inflation factor versus the other p−value 











. . . . . .
t=3
Figure 3.3 Comparison of inflation factor b1 with respect to p2 for different values of
threshold t using using Stouffer’s combining method with n = 2 hypotheses.
For minP combining function, suppose the family will be selected if and only if
min{p1, p2} ≤ tM . Within the selected family, the inflation factor of p1 is
b1 =

t if p2 > t
1 otherwise.
Figure 3.5 is to show b1 versus p2, set t = {0, 0.1, . . . , 1}; the Figure 3.6 is to show
b1 versus t, set p2 = {0, 0.1, 0.2, . . . , 1}.
Remark 3.7. Since the p-values are exchangeable, the inflation factor b2 has the same
tendency as b1.
Now, we want to compare the different selection rules using Fisher’s, minP and
Stouffer’s combining methods. Suppose given the threshold t ∈ [α, 1] for minP selection
rule such that the hypotheses/family is selected if min{p ≤ t}. A simple way to make







log pj ≥ tF
}
= Pr {min{p1, . . . , pn} ≤ t} ,
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inflation factor versus selection cutoff 







Figure 3.4 Comparison of inflation factor b1 with respect to threshold t for different









= Pr {min{p1, . . . , pn} ≤ t} .
It means the chances of the family is selected are the same for these methods.
We use the following calculations find equivalent selection threshold for Fisher’s
and minP combining methods. Here, assume the p-values are identical and independent.






log pj > tF
}
= Pr {min{p1, . . . , pn} ≤ t} ,
which is equivalent to
Pr(T ≥ tF ) = 1− (1− t)n,
where T ∼ χ22n. Then
Pr(T ≤ tF ) = (1− t)n.
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inflation factor versus the other p−value 






. . . . . . 
t=0.9
t=1
Figure 3.5 Comparison of inflation factor b1 with respect to p2 for different values of
threshold t using minP combining method with n = 2 hypotheses.








= Pr {min{p1, . . . , pn} ≤ t} ,
which is equivalent to
Pr(Z ≥ tS) = 1− (1− t)n,
where Z ∼ N(0, 1). Then
Pr(Z ≤ tS) = (1− t)n.
It means for the minP threshold t, we can always find somehow equivalent threshold
tF and tS for Fisher’s and Stouffer’s combining method.
We can also plot the comparison for three combining methods when combining
two hypotheses. From Figure 3.7, we can observe the cross points for different two lines
is the equivalent point for the inflation factor and the other p-value. We also compare
different combining methods by conducting the simulations studies in Section 3.6.1.
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inflation factor versus selection cutoff 













Figure 3.6 Comparison of inflation factor b1 with respect to threshold t for different
values of p2 using minP combining method with n = 2 hypotheses.
3.5.2 Selection Rules Using MTP Controlling k-FWER
It has been discussed that controlling generalized FWER is more suitable than
controlling either FWER or FDR for selecting body systems in clinical safety studies.
Since FWER is too strict and FDR is too liberal in such setting, k-FWER is an error
measure between these two conventional error measures. Using k-FWER controlling
procedure to select BSoI brings two questions. Which procedure should be used for
selecting more signals? How to choose a suitable k?
For multiple hypotheses testing without family structure, it has been shown that
the generalized Sidak procedure is much more powerful than generalized Bonferroni
procedure (Guo and Romano , 2007) under independence. In Section 3.6.1, we will also
compare generalized Sidak and generalized Bonferroni selection rules in the simulation
studies.
Another factor which affects the selection rule is how many fold we need to
choose for k-FWER control for family level. On one hand, choosing k depends on
the requirement of practice, such as clinicians’ experience or clinical research interest.
For example, if there are many body systems in the trial, and we are interested in
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inflation factor versus the other p−value 






Figure 3.7 Comparisons of inflation factor b1 with respect to p2 for equivalent
thresholds of Fisher’s, Stouffer’s and minP combining methods when n = 2.
selecting more body systems, then we can choose k = 2 or k = 3 to allow to make two
or three type 1 errors for the selection. On the other hand, we can also optimize the k
by doing simulations, which will be discussed in Section 3.6.
3.6 Simulation Studies
This section investigates the performance of the proposed two-stage procedure using
simulations under various dependence settings: (i) the p-values are independent both
within body system and across body system; (ii) the p-values are dependent within each
body system and independent of the p-values in other body systems; (iii) the p-values
are independent within each body system and dependent of the p-values in other body
systems.
Since the families contains true nulls and false nulls, it is more reasonable to
use average FDR over selected families (average-FDR) and conditional FDR (cFDR)
for all true null and non-null families respectively to evaluate the performance of the
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procedures, rather than use global FDR or simple FDR of one family. We use analogous
average power over selected families as average power.
3.6.1 Simulations for the Independence Settings
Numerical comparisons for various number of true null families (m0) and true
null individual hypotheses (n0) First of all, we conduct simulations to compare
the proposed procedure using Sidak procedure (similar as Bonferroni procedure) for
global test of minP combination to select families (cFDR-minP-Sidak) with (I) average
FDR controlling procedure using the same selection rule (BB-minP-Sidak), (II) original
double FDR procedure (DFDR) and (III) modified double FDR procedure (DFDR2).
All the simulations are conducted for 2000 times. Set level α = 0.05 for both selection
for family level and testing for individual hypotheses level. Each simulated data set is
based on one-sided one sample Z-test for testing Hij : µ = 0 versus H
′
ij : µ = µ1 > 0.
Set the number of families m to be 10, in each family set the number of hypotheses
n to be 20. We vary the number of all true null families m0 as 2, 4, 6 and 8, and the
number of true null hypotheses in each non-true null family n0 as 5, 10 and 15. Set
µ1 = 3, α = α1 = 0.05
From Figures 3.8 to 3.11, we can see the cFDR-minP and BB procedures using
Sidak selection rule can control FWER for family level, and control average FDR and
conditional FDR under all scenarios. But DFDR and DFDR2 procedure fail to control
average FDR when n0 and m0 become bigger. For example, in Figure 3.10, when
n0 = 15, both DFDR and DFDR2 lines are above 0.05 when the proportion of null
families is greater than 0.4. DFDR and DFDR2 also fail to control conditional FDR as
well.
Numerical comparisons for various combining methods In this section, we
compare the procedures using different combining methods, here we mainly compare
Fisher’s and minP methods. The selection threshold here we used generalized Sidak
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Figure 3.8 From the left to right panels are simulated FWER across families,
conditional FDR for a null family and conditional FDR for a non-null family versus
proportion of null hypotheses in each non-null family (n0/n). From the top to bottom
panels, the numbers of true null families are m0 = 2, 4, 6, 8 out of m = 10 families,
there are n = 20 hypotheses in each family, µ1 = 3, α = α1 = 0.05.
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Figure 3.9 From the left to right panels are simulated average FDR over selected
families, global FDR and average power versus proportion of null hypotheses in each
non-null family (n0/n). From the top to bottom panels, the numbers of true null families
are m0 = 2, 4, 6, 8 out of m = 10 families, there are n = 20 hypotheses in each family,
µ1 = 3, α = α1 = 0.05.
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Figure 3.10 From the left to right panels are simulated FWER across families,
conditional FDR for a null family and conditional FDR for a non-null family versus
proportion of null families (m0/m). From the top to bottom panels, the numbers of
true null hypotheses in each non-null family are n0 = 5, 10, 15 out of n = 20 hypotheses,
there are m = 10 families, µ1 = 3, α = α1 = 0.05.
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Figure 3.11 From the left to right panels are simulated average FDR over selected
families, global FDR and average power versus proportion of null families (m0/m).
From the top to bottom panels, the numbers of true null hypotheses in each non-null
family are n0 = 5, 10, 15 out of n = 20 hypotheses, there are m = 10 families, µ1 = 3,
α = α1 = 0.05.
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Figure 3.12 Comparisons for different combining methods using Sidak selection rules
(k = 1) for independent structure, m = 10, n = 20, n0 = 15, α = α1 = 0.05.
threshold. In Figure 3.12, we can see the proposed procedure using Fisher’s combining
method as FWER selection rule is more powerful than using minP combining method.
But BB procedure using Fisher’s combining method is slightly less powerful than the
one using minP combining method.
However, when considering generalized Sidak procedure with a slightly larger
k, the proposed procedure using minP combining method is still less powerful than
the one using Fisher’s combining method, but the two lines are very close. The BB
procedure using these two combining methods are also almost the same regarding the
power performance, see Figure 3.13.
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Figure 3.13 Comparisons for different combining methods using generalized Sidak
with k = 3 selection rules for independent structure, m = 10, n = 20, n0 = 15,
α = α1 = 0.05.
Now we also consider the simulated average power, average FDR, conditional FDR
for a null family and a non-null family versus different significant level α1 for selecting
families, set α1 = 0.05, 0.1, 0.15, 0.2, 0.25, 0.3, simulate the proportion of containing
signals among the selected families and proportion of detecting signals among selected
families containing signals. From Figure 3.14, we can observe similar results as Figure
3.13. However, from the real data analysis in the later section, in some cases using
minP combing method can find more signals in selecting step. And minP combining is
more convenient to calculate in practice.
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Figure 3.14 Comparisons for different combining method for independent structure
using generalized Sidak with k = 3 selection rules versus different selection significant
level α1.
Numerical comparisons for various k-FWER selection procedures For
different k-FWER selection rule, such as generalized Bonferroni versus generalized
Sidak; choice of k, we also perform some simulation to investigate the differences.
In Figure 3.16, when k becomes larger, the power for cFDR or BB will become
higher, since the procedure allows to make more than one type 1 error in selecting stage,
more families containing signals could be selected. Moreover, the proposed procedures
(cFDR-minP-k-Sidak and cFDR-minP-k-Bonf) are more powerful than BB procedures
(BB-minP-k-Sidak and BB-minP-k-Bonf) when proportion of null families is greater
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Figure 3.15 Comparisons for using generalized Bonferroni and generalized Sidak
selection rules with k = 1, 2, 3 under independence, the plots show the conditional
FDR for null or non-null family versus the proportion of null families, m = 10, n = 20,
n0 = 15, α = α1 = 0.05.
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Figure 3.16 Comparisons for using generalized Bonferroni and generalized Sidak
selection rules with k = 1, 2, 3 under independence, the plots show the average FDR
and average power versus the proportion of null families, m = 10, n = 20, n0 = 15,
α = α1 = 0.05.
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than 0.4. When k becomes larger, the procedures using generalized Sidak selection rule
are more powerful than the procedures using generalized Bonferroni rule.
3.6.2 Simulations for the Dependence Settings
We also perform the simulations under two types of dependence settings: (I) the p-values
are dependent within each body system and independent of the p-values in other body
systems; (II) the p-values are independent within each body system and dependent of
the p-values in other body systems. We consider equal correlated dependence setting
with ρ = 0, 0.1, . . . , 0.9 in the following simulation studies.
From Figures 3.17 and 3.18, we can observe when m0 = 4 out of total 10 families,
the proposed procedure can control average FDR and maintain high powers. When
and correlation ρ is less than 0.4 for m0 = 8 out of total 10 families, the proposed
cFDR controlling procedure can control the average FDR and more powerful than
BB procedure by using generalized Sidak selection rule with fold k = 3. But when
correlation becomes larger, the proposed procedure using generalized Sidak selection
rule cannot control the average FDR, while modified BB procedure using the same
selection rule can control average FDR. Therefore, we recommend to use the cFDR
controlling procedure when proportion of true null families is small (about 40%) and
use the modified BB procedure when proportion of true null families is large (about
80%).
3.7 Real Data Analysis: Clinical Safety Studies
In this section, we apply the proposed cFDR-minP-k-FWER controlling procedure
(Procedure 3.6) in the clinical safety studies to flag the significant AE types. The data
analysis is conducted in the following three steps.
Step 1 (Select body systems) Selecting body system BSi if f(pi1, . . . , pini) ≤
ti, where ti can be the same value for any i or a sequence of thresholds.
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Figure 3.17 Comparisons of conditional FDR’s with respect to ρ for different
dependent structures and different numbers of null families (m0 = 4, 8) by using
different multiple families testing procedures. α = α1 = 0.05.
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Figure 3.18 Comparisons of average FDR’s and powers with respect to ρ for different
dependent structures and different numbers of null families (m0 = 4, 8) by using
different multiple families testing procedures. α = α1 = 0.05.
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We want to control some error rate when selecting the body systems. In different
phases of clinical trials, the adverse experience (AEs) usually are across 5-50 body
systems, and the trials allow to more than one false discoveries on body systems
selection when there are more classified body systems. Thus, we suggest if the number
of body systems is no more than 30, consider generalized FWER (k-FWER) controlling
procedure to select body systems. Otherwise we can consider FDR controlling
procedures. Note for generalized FWER selection rule, k can be decided based on
clinicians’ experience or protocol information.
Step 2 (Conditional inference for flagging AEs) Within each selected body
system Fi : i ∈ S, calculate the conditional p-value for each hypothesis P ′ij, and calculate
corresponding BH adjusted conditional p-value P ′ij
BH-adj.
Step 3 (Make decision) For i ∈ S and j = 1, . . . , ni. If P ′ij
BH-adj ≤ α, then
reject Hij, that is, flag the j-th AE type in the i-th body system.
We consider the following two cases in reality to select body systems of interest,
then flag the significant AE types within the selected body systems.
Case 1: Fixed selection rule and different combining methods are considered. For
instance, let ti = 0.1 for minP combining method. Such a fixed selection rule cannot
guarantee type 1 error rate control across family level.
Case 2: A sequence of data-adaptive thresholds ti to select body systems. For
instance, for i-th family Fi, i = 1, . . . ,m, we set the global null p-value as p̃i = 1− (1−
min
1≤j≤ni
{pij})ni for minP combining method. If the p-values in the family are uniformly
distributed in (0, 1), then p̃i ∼ U(0, 1) for i = 1, . . . ,m. Consider generalized Bonferroni
procedure on the global null p-values. The family is selected if p̃i ≤ kα1m , where k ∈
{1, . . . ,m}. If k = 1, the procedure reduces to Bonferroni procedure, which controls
FWER on family level. We can also apply generalized Sidak procedure on the global




t̃l(1− t̃)m−l = α1.
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Besides considering different selection rules for proposed procedure (fixed selection
threshold ti = 0.1, generalized Sidak with k = 1 and k = 3, minP and Fisher’s
combining methods), we also compare them with (I) simply applying BH procedure
on pooled p-values (Naive BH); (II) ad-hoc version of original double FDR procedure
(DFDR, α1 = 0.05, α = 0.1); (III) modified double FDR procedure (DFDR2); (IV)
average FDR controlling procedure (Original BB) and (V) group BH procedure (GBH).
3.7.1 Example 3.1
This example is from Mehrotra and Heyse (2001). The trial involved a quadrivalent
vaccine containing measles, mumps, rubella, and varicella (MMRV). Participants were
296 healthy toddlers aged 12-18 months who were randomly assigned to two groups (148
for treatment group, 132 for control group). The treatment group received MMRV on
day 0 and controls received MMR on day 0 followed by V on day 42. All participants
received PedvaxHIB on day 0. Safety follow-up used standard AE reporting and the
primary question was to assess local and systemic reactions for the varicella component.
The comparison of AEs was between the treatment group during days 0-42 with the
control group during days 42-84. There are 40 AE types across eight body systems.
The Fisher’s exact test two-sided p-values are calculated based on the counts.
If the selection threshold is fixed t = 0.05, the 5th body system are selected but
there is no AE in this body system detected. If t = 0.1, the 2nd, 5th and 7th body
system are selected and there is one AE in the 5th family is flagged. Even consider an
extreme case, set t = 1, then all families are selected to make the inference, that is,
there is no selection effect on families and no conditional inference. Still only the AE
in the 7th family are detected.
In Example 3.1, there are 40 AE types across eight body systems. The AE types
in the result details are denoted by BS+AE, for example, 503 means Body system No.
5, the third AE. The no multiplicity adjustment approach flags only four AE types
(204, 503, 704, 706) with p ≤ 0.05. The numbers in the parenthesis are numbers of
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Table 3.1 Example of Clinical Safety Study from Mehrotra and Heyse (2001), where
“BS” is Abbreviate of “Body System” and “No.” is the Type of AEs in Each Body
System
BS Family No. AE name X1 X1/N1 X2 X2/N2 p-value
1 1 1 Asthenia/fatigue 57 0.385 40 0.303 0.167
1 1 2 Fever 34 0.230 26 0.197 0.561
1 1 3 Infection.fungal 2 0.014 0 0.000 0.500
1 1 4 Infection.viral 3 0.020 1 0.008 0.625
1 1 5 Malaise 27 0.182 20 0.152 0.525
3 2 1 Anorexia 7 0.047 2 0.015 0.179
3 2 2 Candidiasis.oral 2 0.014 0 0.000 0.500
3 2 3 Constipation 2 0.014 0 0.000 0.500
3 2 4 Diarrhea 24 0.162 10 0.076 0.029
3 2 5 Gastroenteritis 3 0.020 1 0.008 0.625
3 2 6 Nausea 2 0.014 7 0.053 0.089
3 2 7 Vomiting 19 0.128 19 0.144 0.730
5 3 1 Lymphadenopathy 3 0.020 2 0.015 1.000
6 4 1 Dehydration 0 0.000 2 0.015 0.221
8 5 1 Crying 2 0.014 0 0.000 0.500
8 5 2 Insomnia 2 0.014 2 0.015 1.000
8 5 3 Irritability 75 0.507 43 0.326 0.002
9 6 1 Bronchitis 4 0.027 1 0.008 0.375
9 6 2 Congestion.nasal 4 0.027 1 0.008 0.375
9 6 3 Congestion.resp 1 0.007 2 0.015 0.603
9 6 4 Cough 13 0.088 8 0.061 0.497
9 6 5 Infection.resp 28 0.189 20 0.152 0.431
9 6 6 Laryn 2 0.014 1 0.008 1.000
9 6 7 Pharyngitis 13 0.088 8 0.061 0.497
9 6 8 Rhinorrhea 15 0.101 14 0.106 1.000
9 6 9 Sinusitis 3 0.020 1 0.008 0.625
9 6 10 Tonsillitis 2 0.014 1 0.008 1.000
9 6 11 Wheezing 3 0.020 1 0.008 0.625
10 7 1 Bite/sting 4 0.027 0 0.000 0.125
10 7 2 Eczema 2 0.014 0 0.000 0.500
10 7 3 Pruritus 2 0.014 1 0.008 1.000
10 7 4 Rash 13 0.088 3 0.023 0.021
10 7 5 Rash.diaper 6 0.041 2 0.015 0.288
10 7 6 Rash.measles 8 0.054 1 0.008 0.039
10 7 7 Rash.varicella-like 4 0.027 2 0.015 0.687
10 7 8 Urticaria 0 0.000 2 0.015 0.221
10 7 9 Viral.exanthema 1 0.007 2 0.015 0.603
11 8 1 Conjunctivitis 0 0.000 2 0.015 0.221
11 8 2 Otitis.media 18 0.122 14 0.106 0.711
11 8 3 Otorrhea 2 0.014 1 0.008 1.000
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Table 3.2 Flagging AE Types for Example 3.1 under α1 = 0.05 for Selecting BSoI
and α = 0.1 for Detecting AEs
Approach BSoI Flagging AE Types
Naive BH NA 503 (1)
DFDR 5 (1) 503 (1)
DFDR2 5 (1) 503 (1)
GBH NA 503 (1)
Original BB 5 (1) 503 (1)
cFDR-minP-0.1 2,5,7 (3) 503 (1)
cFDR-minP-Sidak 0 0
cFDR-minP-3-Sidak 5 (1) 0
cFDR-Fisher-Sidak 0 0
cFDR-Fisher-3-Sidak 5, 7 (2) 0
selected body systems and numbers of flagging AE Types. Note that Naive BH and
GBH procedure do not provide selection function, so by using these two procedures the
BSoI selections are not applicable (NA).
cFDR-minP-Sidak and cFDR-Fisher-Sidak procedures do not select any body
systems and flag no AE, but cFDR-minP-3-Sidak procedure selects the 5th body system
and cFDR-Fisher-3-Sidak select the 5th and 7th body systems. There is still no AE
flagged. DFDR, DFDR2 and Original BB procedures select the 5th body system and
flag one AE in the body system.
3.7.2 Example 3.2
This example is from Example 4.1 in Mehrotra and Adewale (2012), there are 42 AE
types across six body systems. Figure 1 in that paper shows typical summaries of
tier 2 AE counts from a (hypothetical) clinical trial. The p-values and corresponding
95% confidence intervals for a difference between two independent binomial proportions
using the Miettinen and Nurminen method. The no multiplicity adjustment approach
flags nine AE types (101-106, 305, 404 and 507)
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Table 3.3 Flagging AE Types for Example 3.2 under α1 = 0.05 for Selecting BSoI
and α = 0.1 for Detecting AEs
Approach BSoI Flagging AE Types
Naive BH NA 106 (1)
DFDR 1,3,4,5 (4) 101-106, 305, 404 (8)
DFDR2 1 (1) 101-106 (6)
GBH NA 101-106, 305, 404, 507 (9)
Original BB 1 (1) 106 (1)
cFDR-minP-0.1 1,3,4,5 (4) 101-106 (6)
cFDR-minP-Sidak 1 (1) 101-106 (6)
cFDR-minP-3-Sidak 1,3,4 (3) 101-106 (6)
cFDR-Fisher-Sidak 1 (1) 101-106 (6)
cFDR-Fisher-3-Sidak 1 (1) 101-106 (6)
From Table 3.3, we can see the the naive BH procedure only flags one AE types.
Although double FDR and modified double FDR methods flag eight and six AE types,
but it cannot guarantee FDR control. GBH method can only ensure FDR control
under asymptotic case, but not finite number of AE types. Average FDR controlling
procedure only select one body system and flag one AE type, which is too conservative.
The cFDR with fixed threshold t = 0.1 cannot provide any error control on
body system level, although it selected four body systems. Our proposed cFDR using
generalized Sidak selection rule and minP combining method can select one body system
with k = 1 and three body systems with k = 3. When using Fisher combining method,
the procedures with k = 1 and k = 3 select one body system, which guarantee FWER
control and 3-FWER control at α1 = 0.05 across the body systems.
3.7.3 Example 3.3
This example is from Example 4.2 in Mehrotra and Adewale (2012), there are 49 AE
types across nine body systems. Figure 2 in that paper shows tier 2 AE counts and
related summaries for a double-blind, randomized clinical trial that was designed, in
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Table 3.4 Flagging AE Types for Example 3.3 under α1 = 0.05 for Selecting BSoI
and α = 0.1 for Detecting AEs
Procedures BSoI Flagging AE Types
Naive BH NA 703 (1)
DFDR 3, 7 (2) 301, 704 (2)
DFDR2 7 (1) 703, 704 (2)
GBH NA 301, 401, 703, 704 (4)
Original BB 7 (1) 703 (1)
cFDR-minP-0.1 1, 2, 3, 4, 6, 7 (6) 301, 703, 704(3)
cFDR-minP-Sidak 7 (1) 703, 704 (2)
cFDR-minP-2-Sidak 3, 7 (2) 703, 704 (2)
cFDR-minP-3-Sidak 3, 4, 7 (3) 703, 704 (2)
cFDR-Fisher-Sidak 7 (1) 703, 704 (2)
cFDR-Fisher-2-Sidak 7 (1) 703, 704 (2)
cFDR-Fisher-3-Sidak 3, 4, 6, 7 (4) 703, 704 (2)
part, to compare the safety and efficacy of two medical treatments. The no multiplicity
adjustment approach flags nine AE types (101, 209, 301, 305, 401, 602, 703, and 704).
Table 3.4 shows that the naive BH and original BB procedures flag one AE type
(703), and double FDR and modified double FDR the other methods flag five AE types
(203, 206, 211, 604 and 702).
3.7.4 Example 3.4
This example is from Example 4.3 in Mehrotra and Adewale (2012), there are 64 AE
types across eight body systems. Figure 3 in that paper shows tier 2 AE counts and
related summaries for another clinical trial, using the same format as in the previous
three examples.The no multiplicity adjustment approach flags eight AE types (203, 206,
211, 213, 305, 603, 604, and 702).
From Table 3.5, we can see the naive BH and average FDR methods flag four AE
types (203, 211, 604 and 702), and the other methods flag five AE types (203, 206, 211,
604 and 702).
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Table 3.5 Flagging AE Types for Example 3.4 under α1 = 0.05 for Selecting BSoI
and α = 0.1 for Detecting AEs
Approach BSoI Flagging AE Types
Naive BH NA 203, 211, 604, 702 (4)
DFDR 2, 3, 6, 7 (4) 203, 206, 211, 604, 702 (5)
DFDR2 2, 6, 7 (3) 203, 206, 211, 604, 702 (5)
GBH NA 203, 206, 211, 604, 702 (5)
Origianl BB 2, 6, 7 (3) 203, 211, 604, 702 (4)
cFDR-minP-0.1 1, 2, 3, 6, 7 (5) 203, 206, 211, 604, 702 (5)
cFDR-minP-Sidak 2, 6, 7 (3) 203, 206, 211, 604, 702 (5)
cFDR-minP-3-Sidak 2, 6, 7 (3) 203, 206, 211, 604, 702 (5)
cFDR-Fisher-Sidak 2, 6, 7 (3) 203, 206, 211, 604, 702 (5)
cFDR-Fisher-3-Sidak 2, 6, 7 (3) 203, 206, 211, 604, 702 (5)
3.8 Concluding Remarks
Most existing approaches for two-stage multiple families procedures such as double
FDR, modified double FDR, BB and GBH procedures do not consider the type 1 error
control in both family level and individual level. Selection bias is always existing in those
procedures. In the past, it is also challenge to separate selection effect and multiplicity
effect if the test statistics and select statistics are dependent. In this chapter, by using
conditional inference, we can make valid selective inferences. In clinical safety studies,
the existing double FDR and modified double FDR procedure fail to control FDR based
on our simulation studies. However, similar as these two procedures, by using minimum
p-values, the proposed procedure can guarantee overall FDR control. The procedure
also guarantee k-FWER control for Body System level and conditional FDR for Adverse
Event level.
We summarize the comparisons for different approaches used for multiple families
multiple testing procedures (MTPs) in the Table 3.6. In practice, based on the clinical
safety experience, discoveries across body systems are considerable important and
should be given more attentions for future research. The proposed procedure can
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Table 3.6 Error Rates Control for Different MTPs with Multiple Families Structure
Approach Family level Within selected family Overall
Original DFDR × × ×
DFDR2 FDR × ×
GBH × × global-FDR
p-filter FDR × global-FDR
Original BB FDR × average-FDR
cFDR-minP-t (fixed) × cFDR average-FDR
cFDR-minP-k-Sidak k-FWER cFDR average-FDR
provide suitable type 1 error controls across family level, within selected families and
overall on all families. Based on the simulation studies, the proposed procedures using
specific selection rules can outperform other existing procedures. In clinical safety
studies, the proposed procedures can select some body systems of interest and efficiently
flag the AEs in these body systems.
In this chapter, the recommended procedure using conditional p-value based
on minP combination and generalized Sidak selection rule, which requires p-value
within body system must be independent. But for dependent p-values within body
system, minP or Fisher’s combining method cannot be used. We can consider
Brown’s combining method, which is an extension of Fisher combination, but for
dependent p-values combination. For any dependent global p-values across body system,
generalized Bonferroni or generalized Holm procedure can be considered for selecting the
body systems; for positive dependent global p-values, the generalized step-up k-FWER
procedures in Sarkar (2006) can also be considered. Moreover, we can also consider
applying adaptive procedures (Storey et al., 2004; Sarkar, 2008) on the conditional
p-values to get more powerful procedures. Other problems related to how selection rule
affects the procedures are also interest to solve, such as estimating the proportion of
non-null families (containing signals) among the selected families, and the proportion
of true rejections (detecting signals) among the selected non-null families.
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3.9 Software
The multiple families error rate control methods described in this chapter have been
implemented as a part of the MHTmult R package [Zhu and Guo, 2017], which is
available online at https://cran.r-project.org/web/packages/MHTmult.
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CHAPTER 4
MULTIVARIATE LOGISTIC-TYPE MODELS BASED ON AN
INVERSE SAMPLING SCHEME
4.1 Introduction
In the past half a century there have been many contributions to generalized linear
models (GLMs). The logistic model with the logit link function developed by Cox
(1958) is a very popular generalized linear model. This model is applicable when the
response variable is binary, such as taking two qualitative values (e.g. male/female,
low/high, dead/survived). It is the simplest classification model. A natural extension
here is the multinomial logistic model, where the dependent variable is more than
two categories. The multinomial logistic regression model has been a fundamental
model for developing research in deep learning or softmax regression. The moments
and properties of the negative binomial (NB) distribution are given in Johnson et
al. (1992). In the generalized linear model, when the response variable follows NB
distribution, the variable measures the number of failures until k successes have been
observed. Johnson et al. (1997) describes and analyzes a generalization of the NB
distribution called the negative multinomial distribution (NMn), which can be used to
develop GLM models. Bringing this distribution in GLM, Bonett (1985) proposes NMn
GLM models with linear link and logit link. The GLM considered by Evans and Bonett
(1989) defines a log-linear model for the multilevel contingency tables with negative
multinomial frequency counts and also gives the maximum likelihood estimators.
Dhar (1995) introduces the concept of a generalized inverse sampling scheme
which can be used to study several special events at a time. He derives the Extended
Negative Multinomial distribution (ENMn), the distribution of the frequency counts
under a generalized inverse sampling scheme. Zelterman (1997) proposes an estimate
of the shape parameter based on the mean and quartiles of Pearson’s χ2 statistic.
They also show that the maximum likelihood estimator (MLE) of the shape parameter
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of the negative multinomial distribution cannot be obtained by directly maximizing
the log-likelihood function. Using the EM algorithm, Adamidis (1999) derives the
MLE of the NB distribution’s shape parameter. Dhar and Lahiri (2014) proposes a
log-linear GLM under the ENMn distribution used to study the incidence of cancer.
The parameters of this new model are estimated by the quasi-likelihood method and the
corresponding score function gives a close form estimate of the regression parameters.
Subsequently, the chapter is organized starting with Section 4.2 that introduces
basic notations, concepts and desired statistical properties for the inverse sampling
scheme and multivariate GLM models. In Section 4.3, a new multivariate logistic-
type model is proposed based on the inverse sampling scheme and desired statistical
properties of this model are discussed. Maximum likelihood estimation of the regression
parameters and further inferences, such as confidence intervals, are derived in Section
4.4. Section 4.5 provides model diagnostics and application of this new model. Section
4.6 summarizes findings and discusses potential future work.
4.2 Preliminaries
Basic notations and definitions are introduced to present the multivariate logistic-type
model. Many types of multivariate discrete models are seen in clinical trial and
biomedical research. In particular, categorical data can arise in the experiments where
the distinct outcomes are classified by factors at several levels that consists of the
count number of experimental units formed by these categories. Under these settings,
consider the multinomial (Mn) distribution with exactly G distinct categories and let




pj = 1. Further, for a fixed number of independent identically distributed
trials (n > 1), the probability of observing exactly y1, . . . , yG−1 occurrences of category
1, . . . , G − 1, respectively, is given by Mn(n, p1, . . . , pG−1). In this multinomial trials
setting, consider the G-th category to be of special interest. With this background,
consider the model that counts the number of individuals that fall in each of the 1 to
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G − 1 categories until exactly k individuals of the G-th category have been observed.
Then the probability of exactly y1, . . . , yG−1 individuals of categories 1 . . . , G − 1,
receptively, is given by the negative multinomial distribution NMn(k, p1, . . . , pG−1).
This model is also known as the inverse sampling scheme.
This model was further generalized by Dhar(1995) introducing the extended
negative multinomial (ENMn) model, which is a generalized inverse sampling scheme.
Several special events can be simultaneously analyzed using ENMn. To see its definition,
draw samples until a pre-determined total number of k ≥ 1 special events of different
types that occur are observed out of total distinct types of events G > k. So the
model is called ENMn(k, p1, . . . pG) model. What is interesting is that the ENMn model
also deals with the response vector that counts the various categories. Bringing this
feature of the ENMn distribution into the logistic model, one can propose a GLM of
the logistic-type with random samples of response vector that follows this generalized
inverse sampling scheme. The new GLM developed in this chapter considers log
ratio of expected counts of response categories equal to the linear regression similar
to the multinomial logistic model. The properties of the ENMn distribution within
the multinomial logistic-type model framework makes it applicable to analyze more
practical data sets in the health field. The following section formally introduces the
ENMn distribution.
4.2.1 Generalized Inverse Sampling Scheme
The ENMn distribution also known as generalized inverse sampling scheme, Dhar
(1995), is formally introduced. Consider a multivariate response variable to be
the G-categories Mn distribution. In these multinomial categories, without loss of
generality, consider the first G0 groups of events (E1, . . . , EG0) as common (non-special)
events, and the remaining G1 = G − G0 groups of events (EG0+1, . . . , EG) as special
events. Then in the multinomial trials, keep observing events until k events from the
special group 1, . . . , G0 are observed. The count vector of different groups (special or
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non-special), denoted by y is distributed as ENMn with parameters (k, p1, p2, . . . , pG−1).




yj,i is given by





(p1,i, p2,i, . . . , pG,i)
′. (4.2.1)
Lahiri et al. (2008) also give the variance-covariance of yi, which is a blocking diagonal
matrix. Generalized inverse sampling scheme distribution is part of the exponential
family as can be seen in the following section.
4.2.2 Multivariate Exponential Family
Jorgensen (1983) studies the response variable y follows the distribution from an
exponential family. The exponential family of distribution has the following form
f(y, θ, κ) = c(y, κ) exp{a(κ)t(y, θ)},
where y, θ, κ can be vectors. Thus, the above exponential family can be viewed as
a multivariate generalization of the univariate case. Here a(κ) > 0 and θ is an m-
dimensional parameter.
The ENMn distribution belongs to the exponential family since its probability
distribution function can be expressed as
f(y1,i, . . . , yG−1,i, p1i, . . . , pG−1,i, ki)
=
(y1,i + · · ·+ yG0,i + ki − 1)!ki
y1,i! · · · yG,i!
p
y1,i




(y1,i + · · ·+ yG0,i + ki − 1)!ki









where yG,i = ki −
∑G−1
j=G0+1
yj,i and pG,i = 1 −
∑G−1
j=1 pj,i. Thus, the logistic-type GLM
under ENMn is the class of GLM as considered by Jorgensen (1983). The following
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section introduces a motivating example for the ENMn distribution and describes the
data structure used in a logistic-type GLM under this distribution.
4.2.3 A Motivating Example of ENMn and Data
Therefore, keeping a concrete example in mind when reading this research makes it
easier, consider a sequence of independent trials, which contains several kinds of liver
disease diagnosis as described in Plomteux (1980). This data set is in the form of
multinomial records of one set of liver disease group followed by that of another,
along with the covariates. The study includes 57 cases of acute viral hepatitis (Group
1), 44 cases of persistent chronic hepatitis (Group 2), 40 cases of aggressive chronic
hepatitis (Group 3), and 77 cases of post-necrotic cirrhosis (Group 4). Further, this
data set consists of enzymatic activity measured for the 218 patients giving four liver
enzymes as covariates: aspartate aminotransferase (AST), alanine aminotransferase
(ALT), glutamate dehydrogenase (GLDH) and ornithine carbamyltransferase (OCT).
The four liver disease groups naturally form the categories of the Mn distribution.
Then GLM with response vector following ENMn distribution is simulated as follows.
The four groups counts are aggregated until either Group 3 or Group 4 is observed and
the covariate for a sample here is taken to be that corresponding to average covariate
of the Mn samples involved in it. The independent samples are achieved by randomly
reordering the Plomteux (1980) data. The counts of different groups give rise to a
sample of ENMn distribution with parameters (k = 1, p1, p2, p3, p4) and k = y3 + y4 =
1. Since the available data was randomly reordered, one observes that this reordered
data contains n = 117 independent observations from ENMn(k = 1, p1, p2, p3). In
the following section, the multivariate logistic-type GLM under ENMn distribution is
formally introduced.
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4.3 A Multivariate Logistic-type Model under the ENMn Distribution
Now suppose there are m covariates and G = G0+G1 distinct attributes for a response,
where G1 attributes are of special interest and the remaining are not. Then the
multivariate logistic-type model under the ENMn distribution is defined as follows.
Definition 4.1 (Multivariate Logistic-type GLM). Without loss of generality, let the












, j = G,
(4.3.1)
where vector xi =
(
1, xi,1, xi,2, · · · , xi,m
)′
consists of the m covariates and“1” gives











, j = 1, . . . , G− 1, are the regression coefficients.
Then the estimated response for the i-th sample and j-th category is given by












, j = G.
(4.3.2)













where j = 1, . . . , G−1. Note that these equations are also used to define the traditional
multinomial logistic model. Further, note that in the proposed model, the regression
part is equal to the log ratio of the expectation of a response category to that of the
baseline response category G, which is a log odds ratio.
Remark 4.2. The reference group can be any group in the categories, so it can be either
a common or a special event group in the ENMn model. Without loss of generality,
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pj,i = 1, i = 1, . . . , n, similar to the multinomial logistic regression.

















, j = G,
(4.3.5)
which is used to describe the model diagnostic procedure in Section 4.3. Note that by
(4.3.2) and (4.3.5) p̂j,i = ŷj,i/ki, and a straightforward fact is that when ki = 1, then
p̂j,i = ŷj,i.
So far, the logistic-type GLM model based on an inverse sampling scheme has
been defined. One can now develop the inference and diagnostics for the proposed
model.
4.4 Model Inferences and Diagnostics
4.4.1 Maximum Likelihood Estimation
Estimation of the regression parameters of the proposed model using MLE theory is
developed in this section. The calculation of the MLE for the regression parameter
Fisher’s scoring method is equivalent to an iterative weighted least squares procedure
is proved by Nelder and Wedderburn (1972). Moreover, calculation of the MLE of the
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regression parameter by Fisher’s scoring method is equivalent to the generalized Gauss-
Newton method for calculation of the least squares estimator is shown by Jorgensen
(1983). These approaches are used to do inference for the regression parameter under
multivariate logistic regression models by Glonek and McCullagh (1995). Similar ideas
to obtain the MLE of regression parameter in the proposed model are used. The
likelihood function of the ENMn model is










j=1 yj,i + ki − 1)!ki
y1,i! . . . yG,i!
p
y1,i




where yG,i = ki−
∑G−1
j=G0+1
yj,i and pG,i = 1−
∑G−1
j=1 pj,i. In the special case ki ≡ 1, that
is, one stops Mn trials when one observes an event from either one of the special events
group. Then, the likelihood function becomes




































The score equations can be derived by taking first-order derivative of lnL in (4.4.2)

























































where pj,i is as expressed in (4.3.4).
Setting the derivative in (4.4.3) as equal to 0(G−1)×1 gives the score equations.
MLE β̂ is now obtained by solving these score equations. MLE of β can also be
iteratively obtained by the Newton-Raphson’s algorithm. This algorithm is described
as follows.
Algorithm 4.1.











one can set initial estimate as the MLE of the multinomial logistic regression
parameter.
Step 2: Take





















Step 3: Iterate Steps 1 and 2 until the sequence in (4.4.4) convergence.
Remark 4.3. The estimators of the proposed model are the same as the conventional
multinomial logistic model estimators of the regression parameters. Since the kernel
of the likelihood function (4.4.1) and equations in (4.3.5) are the same as multinomial
logistic regression. Additional inference is developed in the following section.
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4.4.2 Confidence Intervals and Tests
The Fisher scoring method is used to develop the inference. Using this method, the
asymptotic variance-covariance matrix of the β̂ for logistic-type GLM under ENMn is
derived Thus, second-order partial derivatives of the log likelihood with respect to β is





































where j = 1, . . . , G− 1, l = 1, . . . , G− 1, j 6= l. Since xi is (m+ 1)-dimensional vector,
each component as described in (4.4.5) and (4.4.6) of the Hessian is (m+ 1)× (m+ 1)
































Therefore, the estimator of the variance-covariance matrix based on the MLE is
Σ̂ = −H−1|β(j)=β̂(j) . (4.4.8)
The diagonal elements of the matrix Σ̂ are used to get the estimate of the individual
variances of β̂. The confidence interval and hypothesis test for each regression
parameter can be now developed.
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Further, the fact that β̂ is asymptotically multivariate Gaussian is used. Then, the
two-sided 100(1−α)% confidence intervals of the regression parameters can be derived
from (4.4.8) as β̂(j)±z1−α/2
√




0 versus H1 : β̂
(j) 6= β̂(j)0 for each component, Z =
|β̂(j) − β̂(j)0 |√
diag{ ˆV ar(β̂(j))}
component-wise is used.
Remark 4.4. The variance-covariance matrix of β̂ of the proposed model is different
from that of the traditional logistic model. So, confidence intervals, tests of the
regression parameters and model diagnostics are also different. Moreover, when the
proposed model’s distribution is correctly specified as the ENMn distribution, the model
fitting will benefit from the information of special events and the stopping rule.
The goodness-of-fit of the multivariate GLM is developed in the next section.
4.4.3 Model Diagnostics
Similar to Myers et al. (2012), the deviance of the proposed model is computed as
follows.






j=1 yj,i + ki − 1)!ki
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is MLE of pj,i, Dhar (1995), and p̂j,i is as in (4.3.5). A new model
fitting diagnostic based on deviance residuals is now proposed. The deviance residual
for the i-th sample is







, i = 1, . . . , n; j = 1, . . . , G. (4.4.10)
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The normality of the deviance residuals dj,i is used to diagnose the model fit, similar
to Myers et al. (2012). Another approach is to do the model fitting diagnostic based
on the Pearson residuals, instead that of the deviance, which is also used in Dhar et al.




, i = 1, . . . , n; j = 1, . . . , G, (4.4.11)
where ŷj,i is obtained from (4.3.2). These model fitting are used in the application
described in Section 4.5 to compare the proposed model with the multinomial logistic
regression model. Also, the confidence intervals for the different models are computed.
4.5 An Application for the Proposed Model
The multivariate logistic-type GLM under ENMn is fitted to the data explained
in Section 4.2.3. This section demonstrates the virtues of the proposed model in
comparison with the multinomial logistic regression model. In the example, there are
G = 4 groups (Groups 1 to 4), including G0 = 2 (Groups 1 and 2) common event groups
and the rest of G1 = 2 (Groups 3 and 4) special event groups. Denote the covariates in
the proposed model as x1, x2, x3 and x4 which are averages of the enzymes: AST, ALT,
GLDH and OCT corresponding to an ENMn sample as described in Section 4.2.3. Set
the last group (Group 4) as a reference group.
In order to do the model comparison, the Section 4.2.3 data is further reduced
as follows. The multinomial logistic regression model is fitted to the data in Plomteux
(1980) (n=218). Covariates based on large p-values are eliminated. In Tables 4.1 and
4.2 “j:covariate” represents the description of the regression parameter for the j-th
category and corresponding covariate. The analysis result is shown as follows.
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Table 4.1 Regression Results Applying Multinomial Logistic GLM
Estimate Std. Error t-value Pr(>|t|)
1:(intercept) -10.734182 3.058415 -3.509721 0.000449
2:(intercept) 5.804643 2.598270 2.234041 0.025480
3:(intercept) -6.276608 1.773263 -3.539580 0.000401
1:log(X1) -5.171071 1.131643 -4.569525 0.000005
2:log(X1) -6.369987 1.098285 -5.799940 0.000000
3:log(X1) -1.439686 0.648000 -2.221736 0.026301
1:log(X2) 9.300834 1.346797 6.905891 0.000000
2:log(X2) 6.506386 1.073560 6.060569 0.000000
3:log(X2) 2.081067 0.618276 3.365919 0.000763
1:log(X3) -2.025177 1.124202 -1.801434 0.071634
2:log(X3) -1.880089 1.035320 -1.815949 0.069378
3:log(X3) 1.192963 0.590522 2.020183 0.043364
1:log(X4) -1.275437 1.007589 -1.265830 0.205574
2:log(X4) -0.671354 0.795664 -0.843766 0.398800
3:log(X4) 0.010497 0.500557 0.020971 0.983269
From Table 4.1, one can observe the covariate of ln(x4) is not significant at
all categories, so the predictor x4 is eliminated. Thus, keeping the three covariates
ln(x1), ln(x2) and ln(x3), that is, m = 3, the parsimonious model is obtained.
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Table 4.2 Fitted Multinomial Logistic GLM on Parsimonious Model
Estimate Std. Error t-value Pr(>|t|)
1:(intercept) -11.589083 3.087192 -3.753924 0.000174
2:(intercept) 5.509834 2.577567 2.137610 0.032548
3:(intercept) -6.186569 1.591427 -3.887435 0.000101
1:log(X1) -5.544992 1.139901 -4.864450 0.000001
2:log(X1) -6.533954 1.076117 -6.071785 0.000000
3:log(X1) -1.425277 0.639885 -2.227395 0.025921
1:log(X2) 8.784099 1.228232 7.151826 0.000000
2:log(X2) 6.217821 1.007456 6.171801 0.000000
3:log(X2) 2.063563 0.603589 3.418822 0.000629
1:log(X3) -2.728094 0.980222 -2.783138 0.005384
2:log(X3) -2.377281 0.786379 -3.023075 0.002502
3:log(X3) 1.185168 0.407927 2.905341 0.003669
Table 4.2 shows the three covariates are all significant. The results indicate
that β̂ = (−11.59, 5.51,−6.19,−5.55,−6.53,−1.43, 8.78, 6.22, 2.06,−2.73,−2.38, 1.19).
The MLE of regression parameters for the proposed model are the same as that of
multinomial logistic model as mentioned in Remark 4.3. The confidence interval results
for the multinomial logistic regression model are shown in Table 4.3.
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Table 4.3 MLE and 95% Two-sided Confidence Interval of the Regression Parameters
for Multinomial Logistic Regression Model
Index of the parameter β MLE Lower bound Upper bound
1 -11.589083 -17.639172 -5.540112
2 5.509834 0.433103 10.529090
3 -6.186569 -9.304570 -3.067024
4 -5.544992 -7.786518 -3.314742
5 -6.533954 -8.643587 -4.424091
6 -1.425277 -2.678925 -0.170815
7 8.784099 6.383295 11.202516
8 6.217821 4.249069 8.203398
9 2.063563 0.880889 3.247565
10 -2.728094 -4.656752 -0.812217
11 -2.377281 -3.923184 -0.838680
12 1.185168 0.383946 1.982532
In order to estimate confidence interval of the parameters for the proposed model,
one needs to calculate the variance-covariance matrix based on (4.4.7) and (4.4.8), the
results are shown in (4.5.1).

9.65 −0.01 −1.39 −0.67 0.11 0.00 −0.01 −0.03 0.12 −0.01 −0.00 −0.01
−0.01 0.48 −0.45 0.05 −0.01 0.01 −0.01 −0.00 −0.02 0.01 −0.00 −0.01
−1.39 −0.45 0.74 −0.19 −0.00 −0.01 0.01 0.00 0.00 −0.00 −0.00 0.01
−0.67 0.05 −0.19 0.57 −0.01 −0.00 −0.00 0.01 −0.01 −0.00 0.00 0.01
0.11 −0.01 −0.00 −0.01 7.22 −2.07 0.86 −0.84 0.14 −0.02 −0.00 −0.01
0.00 0.01 −0.01 −0.00 −2.07 0.96 −0.58 0.24 0.00 0.01 −0.00 −0.01
−0.01 −0.01 0.01 −0.00 0.86 −0.58 0.49 −0.30 −0.03 −0.00 0.00 0.00
−0.03 −0.00 0.00 0.01 −0.84 0.24 −0.30 0.52 0.00 −0.01 0.00 0.01
0.12 −0.02 0.00 −0.01 0.14 0.00 −0.03 0.00 2.43 −0.32 −0.03 −0.24
−0.01 0.01 −0.00 −0.00 −0.02 0.01 −0.00 −0.01 −0.32 0.24 −0.15 −0.03
−0.00 −0.00 −0.00 0.00 −0.00 −0.00 0.00 0.00 −0.03 −0.15 0.16 −0.01
−0.01 −0.01 0.01 0.01 −0.01 −0.01 0.00 0.01 −0.24 −0.03 −0.01 0.17

(4.5.1)
Now one can derive the 95% two-sided confidence interval for the regression
parameters of the proposed model, which is shown in Table 4.4.
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Table 4.4 MLE and 95% Two-sided Confidence Interval of the Regression Parameters
for the Proposed Logistic-type GLM using ENMn Model
Index of parameters MLE Lower bound Upper bound
1 -11.589083 -17.678111 -5.500056
2 5.509834 4.158039 6.861628
3 -6.186569 -7.868941 -4.504198
4 -5.544992 -7.021851 -4.068132
5 -6.533954 -11.801088 -1.266820
6 -1.425277 -3.348624 0.498070
7 8.784099 7.411104 10.157095
8 6.217821 4.806222 7.629419
9 2.063563 -0.991926 5.119052
10 -2.728094 -3.678583 -1.777606
11 -2.377281 -3.157388 -1.597175
12 1.185168 0.381420 1.988916
To compare the above two models, the MLE and corresponding 95% two-sided
























Figure 4.1 MLE and confidence interval comparisons between the proposed model
and multinomial logistic regression model.
see most confidence intervals for the proposed model are shorter than the multinomial
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logistic model except the β’s with indices 5, 6 and 9, whose covariates are ln(x1) for
Group 2, ln(x1) for Group 3 and ln(x2) for Group 3, respectively. Please note here
that the confidence intervals for both β6 and β9 show that the parameters are not
significant different from zero at level 0.05. If one therefore takes zero for these two
regression parameters, the proposed GLM model under the inverse sampling scheme
can produce more accurate estimation than conventional model when the true response
distribution is ENMn. To illustrate the deviance calculation as shown in (4.4.9), using
the implemented R package, the deviance is 231.1164 for conventional multinomial
logistic model and 226.7065 for the proposed model. The proposed model again shows
to be a better fit than conventional one since the latter has a smaller deviance.
To make comparisons between models, the normal probability plots of the
deviance residual is used. We can compare the models using normal probability or
QQ-plot for deviance residuals and Pearson residuals.

























Figure 4.2 Normal probability plot for deviance residuals comparisons between
multinomial logistic regression model and the proposed model.
From Figures 4.2 and 4.3, one can see that the deviance and Pearson residuals for
the proposed model are spreads closer to the diagonal line than that for the multinomial
logistic model, indicating the former shows a better fit. Since Pearson residual is
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Figure 4.3 Normal probability plot for Pearson residuals comparisons between
multinomial logistic regression model and the proposed model.
standardized, ideally it should be well spread from -3 to 3. However, from Figures
4.2 and 4.3, the Pearson residuals are spread out from −1 to 1 for the multinomial
logistic regression model, again indicating a better fit for the proposed model.
4.6 Conclusion
This chapter presents an applicable generalized linear model using extended negative
multinomial distribution (inverse sampling scheme) with the known multiple categories
and log odds ratio of expected counts. The proposed model is suitable for the data
that is described by recordings of count of different categories of special or non-special
type occurrences and corresponding covariates. By comparison with the multinomial
logistic regression, the proposed model has several benefits such as more accurate
estimation (providing shorter confidence intervals), providing better goodness-of-fit,
model diagnostics, and deviance.
The estimation algorithms currently uses Newton-Raphson’s method to calculate
the estimator of the proposed model. This method is not the only one, Qaqish and
Ivanova (2006) presented an efficient algorithm for parameter estimation. A potential
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work would be to develop an efficient algorithm using similar ideas, which will result
in an alternative inference and model diagnostic. If the inverse sampling scheme
is implemented in clinical settings, then the health industry can benefit from the
optimality of the sampling design that is incorporated in the proposed model.
4.7 Software
The proposed GLM model in this chapter has been implemented in mvlogit R




CONCLUSION AND FUTURE WORK
In this dissertation, we considered testing multiple hypotheses with discrete data and
multiple families structure and developed novel methods which exploit these inherent
data structures. We also considered categorical data which contains several special
events of interest and developed a logistic-type multivariate model by using inverse
sampling scheme. Those multiple testing and generalized linear model methodology
can be applied in clinical trial and biomedical health care research.
In Chapter 2, we have developed several FWER controlling procedures for discrete
data by exploiting the information of discreteness for test statistics. The proposed
procedures control FWER under various dependence structure. Real data analysis
in both clinical safety studies and cDNA transcript data reveals that the proposed
procedures have more chance to detect signals than conventional procedures in terms of
adjusted p-values. The simulation results imply that the proposed stepwise procedures
outperform the discrete procedures in terms of minimal power. A future work is to
explore optimality of the suggested Procedure 2.1 and 2.3 under arbitrary dependence,
which means for some joint distribution of the discrete p-values, one cannot increase
even one of the critical constants while keeping the remaining fixed without losing
control of the FWER. Another possible future work is to incorporate some data
driven weights into our current proposed procedures to develop more powerful FWER
controlling procedures for discrete data, such as weighted Hochberg type procedure.
In Chapter 3, by using conditional inference and tool of conditional p-value,
we can make valid selective inferences. In clinical safety studies, the existing double
FDR and modified double FDR procedure fail to control average and conditional FDR
based on our simulation studies. However, by using similar screening with minimum
p-values, the proposed procedure can guarantee overall FDR control. In this chapter, we
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recommend a two-stage procedure using conditional p-value based on minP combination
and generalized Sidak selection rule, which requires p-value within body system must
be independent. But for dependent p-values within body system, minP or Fisher’s
combining method cannot be used. We can consider Brown’s combining method, which
is an extension of Fisher combination, but for dependent p-values combination. For
any dependent global p-values across body system, generalized Bonferroni or generalized
Holm procedure can be considered for selecting the body systems; for positive dependent
global p-values, the generalized step-up k-FWER procedures in Sarkar (2006) [62] can
also be considered. Moreover, we can also consider applying adaptive procedures
(Storey et al., 2004; Sarkar, 2008) on the conditional p-values to get more powerful
procedures. Other problems related to how selection rule affects the procedures such as
estimating the proportion of non-null families (containing signals) among the selected
families, the proportion of true rejections (detecting signals) among the selected non-null
families, are also interesting.
In Chapter 4, we present a novel generalized linear model using extended negative
multinomial (inverse sampling scheme) with the known multiple categories log ratio
of expected count. The proposed model is suitable for different categories in several
samples, the observations of each sample share common covariates information. By
comparing with the conventional multinomial logistic regression model, the proposed
model have several benefits such as more accurate estimation (providing shorter
confidence intervals), have a better goodness-of-fit in model diagnostics. A potential
work is to apply the inverse sampling scheme on ordinal multinomial logistic regression
model, which is also widely used in social science research, such as marketing survey.
One can compare the new model with the conventional ordinal multinomial logistic
model in terms of MLE, confidence interval and model diagnostics.
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APPENDIX A
SIMULATION RESULTS IN CHAPTER 2
This appendix contains the simulation results stated but not shown in Chapter 2.
A.1 Independent Simulation Results
The simulation results under independent setting for stepwise procedures comparisons
are shown in this section. Table A.1 and Table A.2 are single-step procedures
comparisons using Fisher Exact Test, and Table A.3 and Table A.4 are single-step
procedures comparisons Binomial Exact Test. Table A.5 and Table A.6 are step-down
procedures comparisons using Fisher Exact Test. Table A.7 and Table A.8 are step-up
procedures comparisons using Fisher Exact Test.
A.2 Dependent Simulation Data Generation and Results
Step 1: Generate dependent Poisson observed counts for each group
In order to generatem dependent EBT statistics Ti, we use the following algorithm
to generate m dependent Poisson random variables within each group, note the Poisson
random variables between two groups are independent.
1. Generate m independent Poisson random variable Y1i ∼ Poi((1 − ρ)λ1i) =
Poi(2(1− ρ)) and one Y01 ∼ Poi(ρλ1i) = Poi(2ρ).
2. Let X1i = Y1i + Y10, then X1i ∼ Poi(2) are dependent for i = 1, . . . ,m, and the














for i, j = 1, . . . ,m and i 6= j.
3. For i = 1, . . . ,m0, generate m0 independent Poisson random variable Y2i ∼
Poi((1 − ρ)λ2i) = Poi(2(1 − ρ)) and one Y20 ∼ Poi(ρλ2i) = Poi(2ρ). For
i = m0 + 1, . . . ,m, generate m − m0 independent Poisson random variable
Y2i ∼ Poi((1− ρ)λ2i) = Poi(10(1− ρ)) and one Y ′20 ∼ Poi(ρλ2i) = Poi(10ρ).
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4. Let X2i = Y2i + Y20 for i = 1, . . . ,m0, then X2i ∼ Poi(2) are dependent for i =













= ρ for i, j = 1, . . . ,m0 and i 6= j; let X2i = Y2i + Y ′20 for
i = m0 + 1, . . . ,m, then X2i ∼ Poi(10) are dependent for i = m0 + 1, . . . ,m, and













= ρ for i, j = m0 + 1, . . . ,m and i 6= j.
Step 2: Obtain the conditional test statistics
Since the generated Poisson random variables between two groups are independent,
we can directly conduct EBT for each hypothesis. after generating Poisson observed
counts x1i and x2i, let ci = x1i + x2i be the total observed count for two groups. Then
the test statistics Ti is conditional test statistics Xi1 given X1i + X2i = ci. Then the
critical value is observed count x1i.
Step 3: Conditional distribution of the test statistics
Based on the conditional inference in Lehman and Romano (2005). which is the
EBT in our paper, the conditional distribution of X1i given X1i +X2i = ci is binomial




Step 4: Calculate available p-value Pi and attainable p-values When Hi
is true, λ1i = λ2i, then pi = 0.5. That is, X1i|X1i + X2i = ci ∼ Bin(ci, 0.5) under null
Hi. Therefore, the available conditional p-value for Hi can be calculated by


















The corresponding attainable p-values can be calculated by







0.5ci for x = 0, 1, . . . , ci. (A.2.2)
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Table A.1 Simulated FWER Comparisons for Single-step Procedures with
Independent p-values Generated from Fisher’s Exact Test Statistics
N = 25 N = 50 N = 75 N = 100 N = 125 N = 150
m = 5
π0 = 0.2
MBonf 0.0025 0.0060 0.0035 0.0075 0.0075 0.0095
Tarone 0.0015 0.0030 0.0015 0.0055 0.0045 0.0085
Bonf 0.0010 0.0030 0.0015 0.0055 0.0045 0.0085
Sidak 0.0010 0.0030 0.0015 0.0055 0.0045 0.0085
m = 5
π0 = 0.4
MBonf 0.0045 0.0130 0.0120 0.0170 0.0135 0.0145
Tarone 0.0030 0.0060 0.0065 0.0140 0.0090 0.0100
Bonf 0.0015 0.0060 0.0065 0.0140 0.0090 0.0100
Sidak 0.0015 0.0060 0.0065 0.0140 0.0090 0.0100
m = 5
π0 = 0.6
MBonf 0.0085 0.0200 0.0195 0.0235 0.0225 0.0245
Tarone 0.0060 0.0105 0.0105 0.0180 0.0155 0.0170
Bonf 0.0025 0.0100 0.0105 0.0180 0.0155 0.0170
Sidak 0.0025 0.0100 0.0105 0.0180 0.0160 0.0175
m = 5
π0 = 0.8
MBonf 0.0140 0.0265 0.0270 0.0340 0.0315 0.0370
Tarone 0.0110 0.0140 0.0155 0.0245 0.0215 0.0220
Bonf 0.0045 0.0135 0.0155 0.0245 0.0215 0.0220
Sidak 0.0045 0.0135 0.0155 0.0245 0.0220 0.0230
m = 10
π0 = 0.2
MBonf 0.0020 0.0060 0.0100 0.0115 0.0095 0.0110
Tarone 0.0005 0.0040 0.0065 0.0060 0.0070 0.0060
Bonf 0.0005 0.0040 0.0065 0.0060 0.0070 0.0060
Sidak 0.0005 0.0040 0.0065 0.0060 0.0070 0.0060
m = 10
π0 = 0.4
MBonf 0.0050 0.0145 0.0165 0.0190 0.0215 0.0190
Tarone 0.0025 0.0090 0.0120 0.0100 0.0140 0.0125
Bonf 0.0025 0.0090 0.0120 0.0100 0.0140 0.0125
Sidak 0.0025 0.0090 0.0120 0.0110 0.0145 0.0130
m = 10
π0 = 0.6
MBonf 0.0090 0.0245 0.0260 0.0265 0.0300 0.0255
Tarone 0.0055 0.0150 0.0185 0.0150 0.0180 0.0155
Bonf 0.0045 0.0140 0.0185 0.0150 0.0180 0.0155
Sidak 0.0045 0.0140 0.0185 0.0160 0.0195 0.0155
m = 10
π0 = 0.8
MBonf 0.0175 0.0335 0.0345 0.0370 0.0390 0.0360
Tarone 0.0090 0.0215 0.0225 0.0190 0.0220 0.0200
Bonf 0.0055 0.0190 0.0225 0.0190 0.0220 0.0200
Sidak 0.0055 0.0190 0.0225 0.0210 0.0240 0.0200
m = 15
π0 = 0.2
MBonf 0.0040 0.0060 0.0065 0.0120 0.0080 0.0100
Tarone 0.0020 0.0030 0.0030 0.0065 0.0045 0.0070
Bonf 0.0005 0.0030 0.0030 0.0065 0.0045 0.0070
Sidak 0.0005 0.0030 0.0030 0.0075 0.0045 0.0070
m = 15
π0 = 0.4
MBonf 0.0090 0.0150 0.0140 0.0240 0.0210 0.0200
Tarone 0.0060 0.0075 0.0065 0.0125 0.0150 0.0105
Bonf 0.0010 0.0070 0.0065 0.0125 0.0150 0.0105
Sidak 0.0010 0.0070 0.0065 0.0145 0.0150 0.0105
m = 15
π0 = 0.6
MBonf 0.0165 0.0250 0.0210 0.0325 0.0320 0.0280
Tarone 0.0090 0.0130 0.0095 0.0170 0.0205 0.0180
Bonf 0.0020 0.0105 0.0095 0.0170 0.0205 0.0180
Sidak 0.0020 0.0105 0.0095 0.0190 0.0205 0.0180
m = 15
π0 = 0.8
MBonf 0.0210 0.0345 0.0315 0.0400 0.0460 0.0360
Tarone 0.0115 0.0170 0.0155 0.0215 0.0285 0.0240
Bonf 0.0020 0.0135 0.0155 0.0215 0.0285 0.0240
Sidak 0.0020 0.0135 0.0155 0.0240 0.0285 0.0240
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Table A.2 Simulated Minimal Power Comparisons for Single-step Procedures with
Independent p-values Generated from Fisher’s Exact Test Statistics
N = 25 N = 50 N = 75 N = 100 N = 125 N = 150
m = 5
π0 = 0.2
MBonf 0.2550 0.5060 0.6855 0.8195 0.9145 0.9505
Tarone 0.1945 0.3900 0.5775 0.7680 0.8655 0.9275
Bonf 0.1125 0.3825 0.5765 0.7680 0.8655 0.9275
Sidak 0.1125 0.3825 0.5850 0.7680 0.8710 0.9340
m = 5
π0 = 0.4
MBonf 0.2110 0.4085 0.5785 0.7405 0.8375 0.9025
Tarone 0.1605 0.3110 0.4715 0.6705 0.7695 0.8625
Bonf 0.0880 0.3000 0.4700 0.6705 0.7695 0.8625
Sidak 0.0880 0.3000 0.4770 0.6705 0.7765 0.8680
m = 5
π0 = 0.6
MBonf 0.1550 0.3130 0.4320 0.5835 0.7025 0.7845
Tarone 0.1180 0.2365 0.3370 0.5145 0.6255 0.7245
Bonf 0.0605 0.2190 0.3355 0.5145 0.6255 0.7245
Sidak 0.0605 0.2190 0.3420 0.5145 0.6330 0.7345
m = 5
π0 = 0.8
MBonf 0.0945 0.1800 0.2570 0.3595 0.4660 0.5505
Tarone 0.0740 0.1330 0.1920 0.2955 0.3950 0.4850
Bonf 0.0330 0.1190 0.1920 0.2955 0.3950 0.4850
Sidak 0.0330 0.1190 0.1955 0.2955 0.4025 0.5005
m = 10
π0 = 0.2
MBonf 0.3155 0.6130 0.8090 0.9110 0.9765 0.9930
Tarone 0.2075 0.4695 0.7220 0.8550 0.9415 0.9820
Bonf 0.1575 0.4660 0.7220 0.8550 0.9415 0.9820
Sidak 0.1575 0.4660 0.7220 0.8595 0.9425 0.9830
m = 10
π0 = 0.4
MBonf 0.2700 0.5220 0.7180 0.8455 0.9440 0.9750
Tarone 0.1770 0.3905 0.6065 0.7720 0.8905 0.9505
Bonf 0.1235 0.3795 0.6065 0.7720 0.8905 0.9505
Sidak 0.1235 0.3795 0.6065 0.7775 0.8920 0.9575
m = 10
π0 = 0.6
MBonf 0.2005 0.4030 0.5615 0.7300 0.8450 0.9035
Tarone 0.1330 0.2990 0.4525 0.6315 0.7590 0.8525
Bonf 0.0800 0.2825 0.4525 0.6315 0.7590 0.8525
Sidak 0.0800 0.2825 0.4525 0.6375 0.7615 0.8585
m = 10
π0 = 0.8
MBonf 0.1115 0.2440 0.3500 0.4775 0.6140 0.6935
Tarone 0.0760 0.1680 0.2645 0.3810 0.5165 0.6060
Bonf 0.0390 0.1555 0.2645 0.3810 0.5165 0.6060
Sidak 0.0390 0.1555 0.2645 0.3880 0.5170 0.6185
m = 15
π0 = 0.2
MBonf 0.3370 0.6715 0.8820 0.9495 0.9915 0.9965
Tarone 0.2520 0.4995 0.7530 0.8910 0.9765 0.9895
Bonf 0.1390 0.4870 0.7515 0.8910 0.9765 0.9895
Sidak 0.1390 0.4870 0.7515 0.8960 0.9765 0.9895
m = 15
π0 = 0.4
MBonf 0.2880 0.5815 0.7910 0.9025 0.9635 0.9830
Tarone 0.2110 0.4105 0.6475 0.8050 0.9335 0.9745
Bonf 0.1030 0.3870 0.6460 0.8050 0.9335 0.9745
Sidak 0.1030 0.3870 0.6460 0.8125 0.9335 0.9745
m = 15
π0 = 0.6
MBonf 0.2135 0.4485 0.6570 0.7925 0.8840 0.9500
Tarone 0.1495 0.3070 0.5085 0.6730 0.8315 0.9140
Bonf 0.0700 0.2760 0.5065 0.6730 0.8315 0.9140
Sidak 0.0700 0.2760 0.5065 0.6790 0.8315 0.9140
m = 15
π0 = 0.8
MBonf 0.1205 0.2635 0.4270 0.5490 0.6710 0.7780
Tarone 0.0830 0.1785 0.3050 0.4295 0.5890 0.7020
Bonf 0.0335 0.1480 0.3040 0.4290 0.5890 0.7020
Sidak 0.0335 0.1480 0.3040 0.4345 0.5895 0.7020
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Table A.3 Simulated FWER Comparisons for Single-step Procedures with
Independent p-values Generated from Binomial Exact Test Statistics
π0 = 0.2 π0 = 0.4 π0 = 0.6 π0 = 0.8
m = 5
α = 0.05
MBonf 0.0020 0.0060 0.0075 0.0165
Tarone 0.0010 0.0030 0.0055 0.0105
Bonf 0.0010 0.0020 0.0025 0.0030
Sidak 0.0010 0.0020 0.0025 0.0030
m = 10
α = 0.05
MBonf 0.0010 0.0045 0.0130 0.0160
Tarone 0.0000 0.0010 0.0050 0.0115
Bonf 0.0000 0.0005 0.0025 0.0025
Sidak 0.0000 0.0005 0.0025 0.0025
m = 15
α = 0.05
MBonf 0.0010 0.0065 0.0045 0.0150
Tarone 0.0000 0.0010 0.0020 0.0070
Bonf 0.0000 0.0005 0.0000 0.0000
Sidak 0.0000 0.0005 0.0000 0.0000
m = 5
α = 0.1
MBonf 0.0070 0.0125 0.0200 0.0365
Tarone 0.0020 0.0065 0.0110 0.0285
Bonf 0.0020 0.0055 0.0065 0.0130
Sidak 0.0020 0.0055 0.0065 0.0130
m = 10
α = 0.1
MBonf 0.0040 0.0080 0.0275 0.0350
Tarone 0.0000 0.0030 0.0165 0.0195
Bonf 0.0000 0.0015 0.0055 0.0060
Sidak 0.0000 0.0015 0.0055 0.0060
m = 15
α = 0.1
MBonf 0.0060 0.0155 0.0185 0.0315
Tarone 0.0005 0.0060 0.0045 0.0200
Bonf 0.0000 0.0010 0.0020 0.0025
Sidak 0.0000 0.0010 0.0020 0.0025
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Table A.4 Simulated Minimal Power Comparisons for Single-step Procedures with
Independent p-values Generated from Binomial Exact Test Statistics
π0 = 0.2 π0 = 0.4 π0 = 0.6 π0 = 0.8
m = 5
α = 0.05
MBonf 0.9205 0.8805 0.7845 0.5565
Tarone 0.8815 0.8240 0.7395 0.5235
Bonf 0.8735 0.8055 0.6610 0.4045
Sidak 0.8735 0.8055 0.6610 0.4045
m = 10
α = 0.05
MBonf 0.9850 0.9635 0.9035 0.7390
Tarone 0.9470 0.9240 0.8630 0.6855
Bonf 0.9315 0.8635 0.7050 0.4775
Sidak 0.9315 0.8635 0.7050 0.4775
m = 15
α = 0.05
MBonf 0.9925 0.9810 0.9555 0.8210
Tarone 0.9825 0.9500 0.9095 0.7845
Bonf 0.9820 0.9475 0.8560 0.6135
Sidak 0.9820 0.9475 0.8560 0.6135
m = 5
α = 0.1
MBonf 0.9680 0.9415 0.8615 0.6330
Tarone 0.9410 0.9140 0.8240 0.5920
Bonf 0.9050 0.8375 0.7040 0.4520
Sidak 0.9050 0.8375 0.7040 0.4520
m = 10
α = 0.1
MBonf 0.9965 0.9875 0.9620 0.8315
Tarone 0.9885 0.9660 0.9170 0.7835
Bonf 0.9870 0.9565 0.8690 0.6600
Sidak 0.9870 0.9565 0.8690 0.6600
m = 15
α = 0.1
MBonf 0.9995 0.9970 0.9830 0.9030
Tarone 0.9960 0.9930 0.9605 0.8400
Bonf 0.9880 0.9615 0.8830 0.6515
Sidak 0.9895 0.9635 0.8880 0.6590
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Table A.5 Simulated FWER Comparisons for Step-down Procedures with
Independent p-values Generated from Fisher’s Exact Test Statistics
N = 25 N = 50 N = 75 N = 100 N = 125 N = 150
m = 5
π0 = 0.2
MHolm 0.0030 0.0090 0.0065 0.0115 0.0150 0.0150
TH∗ 0.0015 0.0045 0.0030 0.0075 0.0090 0.0140
Holm 0.0010 0.0045 0.0030 0.0075 0.0090 0.0140
m = 5
π0 = 0.4
MHolm 0.0055 0.0155 0.0135 0.0230 0.0225 0.0225
TH∗ 0.0030 0.0080 0.0080 0.0185 0.0140 0.0180
Holm 0.0020 0.0075 0.0080 0.0185 0.0140 0.0180
m = 5
π0 = 0.6
MHolm 0.0100 0.0215 0.0215 0.0290 0.0305 0.0320
TH∗ 0.0065 0.0115 0.0115 0.0220 0.0185 0.0205
Holm 0.0030 0.0110 0.0115 0.0220 0.0185 0.0205
m = 5
π0 = 0.8
MHolm 0.0155 0.0285 0.0285 0.0360 0.0375 0.0440
TH∗ 0.0115 0.0145 0.0160 0.0260 0.0240 0.0270
Holm 0.0050 0.0140 0.0160 0.0260 0.0240 0.0270
m = 10
π0 = 0.2
MHolm 0.0020 0.0070 0.0125 0.0130 0.0160 0.0185
TH∗ 0.0005 0.0040 0.0070 0.0080 0.0115 0.0125
Holm 0.0005 0.0040 0.0070 0.0080 0.0115 0.0125
m = 10
π0 = 0.4
MHolm 0.0050 0.0155 0.0200 0.0215 0.0280 0.0265
TH∗ 0.0025 0.0090 0.0125 0.0125 0.0200 0.0175
Holm 0.0025 0.0090 0.0125 0.0125 0.0200 0.0175
m = 10
π0 = 0.6
MHolm 0.0095 0.0250 0.0285 0.0290 0.0360 0.0350
TH∗ 0.0060 0.0150 0.0185 0.0155 0.0220 0.0215
Holm 0.0045 0.0140 0.0185 0.0155 0.0220 0.0215
m = 10
π0 = 0.8
MHolm 0.0175 0.0340 0.0360 0.0380 0.0420 0.0405
TH∗ 0.0090 0.0215 0.0235 0.0195 0.0255 0.0230
Holm 0.0055 0.0190 0.0225 0.0195 0.0255 0.0230
m = 15
π0 = 0.2
MHolm 0.0045 0.0070 0.0070 0.0140 0.0125 0.0120
TH∗ 0.0025 0.0035 0.0030 0.0090 0.0060 0.0085
Holm 0.0005 0.0030 0.0030 0.0090 0.0060 0.0085
m = 15
π0 = 0.4
MHolm 0.0095 0.0165 0.0145 0.0255 0.0255 0.0285
TH∗ 0.0060 0.0080 0.0075 0.0160 0.0175 0.0165
Holm 0.0010 0.0070 0.0075 0.0160 0.0175 0.0165
m = 15
π0 = 0.6
MHolm 0.0165 0.0260 0.0215 0.0345 0.0350 0.0345
TH∗ 0.0090 0.0130 0.0105 0.0190 0.0215 0.0195
Holm 0.0020 0.0105 0.0100 0.0190 0.0215 0.0195
m = 15
π0 = 0.8
MHolm 0.0215 0.0350 0.0315 0.0415 0.0465 0.0390
TH∗ 0.0120 0.0170 0.0165 0.0225 0.0290 0.0260
Holm 0.0020 0.0135 0.0165 0.0225 0.0290 0.0260
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Table A.6 Simulated Minimal Power Comparisons for Step-down Procedures with
Independent p-values Generated from Fisher’s Exact Test Statistics
N = 25 N = 50 N = 75 N = 100 N = 125 N = 150
m = 5
π0 = 0.2
MHolm 0.2555 0.5070 0.6855 0.8200 0.9145 0.9505
TH∗ 0.1945 0.3905 0.5780 0.7680 0.8660 0.9280
Holm 0.1130 0.3830 0.5770 0.7680 0.8660 0.9280
m = 5
π0 = 0.4
MHolm 0.2120 0.4090 0.5790 0.7405 0.8375 0.9030
TH∗ 0.1605 0.3115 0.4725 0.6705 0.7695 0.8630
Holm 0.0880 0.3005 0.4710 0.6705 0.7695 0.8630
m = 5
π0 = 0.6
MHolm 0.1555 0.3150 0.4330 0.5855 0.7035 0.7855
TH∗ 0.1185 0.2365 0.3375 0.5160 0.6265 0.7260
Holm 0.0605 0.2190 0.3360 0.5160 0.6265 0.7260
m = 5
π0 = 0.8
MHolm 0.0950 0.1815 0.2585 0.3615 0.4690 0.5530
TH∗ 0.0745 0.1330 0.1920 0.2965 0.3960 0.4860
Holm 0.0330 0.1190 0.1920 0.2965 0.3960 0.4860
m = 10
π0 = 0.2
MHolm 0.3160 0.6130 0.8095 0.9120 0.9765 0.9930
TH∗ 0.2075 0.4700 0.7220 0.8550 0.9415 0.9820
Holm 0.1575 0.4660 0.7220 0.8550 0.9415 0.9820
m = 10
π0 = 0.4
MHolm 0.2705 0.5220 0.7185 0.8455 0.9445 0.9750
TH∗ 0.1770 0.3905 0.6065 0.7720 0.8905 0.9505
Holm 0.1235 0.3795 0.6065 0.7720 0.8905 0.9505
m = 10
π0 = 0.6
MHolm 0.2010 0.4035 0.5615 0.7300 0.8450 0.9035
TH∗ 0.1330 0.2990 0.4525 0.6315 0.7590 0.8525
Holm 0.0800 0.2825 0.4525 0.6315 0.7590 0.8525
m = 10
π0 = 0.8
MHolm 0.1115 0.2440 0.3500 0.4780 0.6145 0.6935
TH∗ 0.0760 0.1680 0.2645 0.3810 0.5175 0.6065
Holm 0.0390 0.1555 0.2645 0.3810 0.5175 0.6065
m = 15
π0 = 0.2
MHolm 0.3375 0.6715 0.8820 0.9495 0.9915 0.9965
TH∗ 0.2520 0.4995 0.7530 0.8910 0.9765 0.9895
Holm 0.1390 0.4870 0.7515 0.8910 0.9765 0.9895
m = 15
π0 = 0.4
MHolm 0.2885 0.5825 0.7915 0.9025 0.9635 0.9830
TH∗ 0.2110 0.4105 0.6475 0.8055 0.9335 0.9745
Holm 0.1030 0.3870 0.6460 0.8055 0.9335 0.9745
m = 15
π0 = 0.6
MHolm 0.2135 0.4495 0.6575 0.7930 0.8840 0.9500
TH∗ 0.1495 0.3070 0.5085 0.6730 0.8315 0.9140
Holm 0.0700 0.2760 0.5065 0.6730 0.8315 0.9140
m = 15
π0 = 0.8
MHolm 0.1205 0.2645 0.4280 0.5495 0.6730 0.7780
TH∗ 0.0835 0.1785 0.3055 0.4295 0.5890 0.7030
Holm 0.0335 0.1480 0.3045 0.4290 0.5890 0.7030
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Table A.7 Simulated FWER Comparisons for Step-up Procedures with Independent
p-values Generated from Fisher’s Exact Test Statistics
N = 25 N = 50 N = 75 N = 100 N = 125 N = 150
m = 5
π0 = 0.2
MHoch 0.0030 0.0090 0.0070 0.0115 0.0150 0.0155
Roth 0.0020 0.0045 0.0040 0.0085 0.0115 0.0155
Hoch 0.0015 0.0045 0.0040 0.0085 0.0115 0.0155
m = 5
π0 = 0.4
MHoch 0.0060 0.0155 0.0140 0.0235 0.0230 0.0245
Roth 0.0035 0.0080 0.0085 0.0185 0.0160 0.0200
Hoch 0.0025 0.0075 0.0085 0.0185 0.0160 0.0200
m = 5
π0 = 0.6
MHoch 0.0105 0.0215 0.0215 0.0290 0.0305 0.0325
Roth 0.0065 0.0115 0.0115 0.0220 0.0195 0.0215
Hoch 0.0030 0.0110 0.0115 0.0220 0.0195 0.0215
m = 5
π0 = 0.8
MHoch 0.0160 0.0285 0.0285 0.0360 0.0380 0.0445
Roth 0.0115 0.0145 0.0160 0.0265 0.0245 0.0280
Hoch 0.0050 0.0140 0.0160 0.0265 0.0245 0.0280
m = 10
π0 = 0.2
MHoch 0.0025 0.0070 0.0125 0.0140 0.0170 0.0200
Roth 0.0005 0.0040 0.0070 0.0080 0.0120 0.0135
Hoch 0.0005 0.0040 0.0070 0.0080 0.0120 0.0135
m = 10
π0 = 0.4
MHoch 0.0055 0.0155 0.0200 0.0225 0.0290 0.0275
Roth 0.0025 0.0090 0.0125 0.0125 0.0200 0.0185
Hoch 0.0025 0.0090 0.0125 0.0125 0.0200 0.0185
m = 10
π0 = 0.6
MHoch 0.0095 0.0250 0.0285 0.0290 0.0360 0.0350
Roth 0.0060 0.0150 0.0185 0.0155 0.0220 0.0215
Hoch 0.0045 0.0140 0.0185 0.0155 0.0220 0.0215
m = 10
π0 = 0.8
MHoch 0.0180 0.0340 0.0360 0.0380 0.0420 0.0405
Roth 0.0095 0.0210 0.0235 0.0195 0.0255 0.0235
Hoch 0.0055 0.0190 0.0225 0.0195 0.0255 0.0235
m = 15
π0 = 0.2
MHoch 0.0045 0.0070 0.0070 0.0140 0.0125 0.0130
Roth 0.0020 0.0035 0.0030 0.0090 0.0060 0.0095
Hoch 0.0005 0.0030 0.0030 0.0090 0.0060 0.0095
m = 15
π0 = 0.4
MHoch 0.0100 0.0165 0.0145 0.0255 0.0255 0.0290
Roth 0.0060 0.0080 0.0075 0.0160 0.0175 0.0165
Hoch 0.0010 0.0070 0.0075 0.0160 0.0175 0.0165
m = 15
π0 = 0.6
MHoch 0.0175 0.0260 0.0215 0.0345 0.0350 0.0345
Roth 0.0090 0.0130 0.0105 0.0190 0.0220 0.0195
Hoch 0.0020 0.0105 0.0100 0.0190 0.0220 0.0195
m = 15
π0 = 0.8
MHoch 0.0215 0.0350 0.0315 0.0415 0.0465 0.0390
Roth 0.0120 0.0170 0.0165 0.0225 0.0290 0.0265
Hoch 0.0020 0.0135 0.0165 0.0225 0.0290 0.0265
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Table A.8 Simulated Minimal Power Comparisons for Step-up Procedures with
Independent p-values Generated from Fisher’s Exact Test Statistics
N = 25 N = 50 N = 75 N = 100 N = 125 N = 150
m = 5
π0 = 0.2
MHoch 0.2600 0.5075 0.6885 0.8240 0.9170 0.9525
Roth 0.1975 0.3915 0.5820 0.7685 0.8695 0.9300
Hoch 0.1170 0.3845 0.5810 0.7685 0.8695 0.9300
m = 5
π0 = 0.4
MHoch 0.2155 0.4105 0.5810 0.7410 0.8400 0.9055
Roth 0.1630 0.3115 0.4755 0.6705 0.7715 0.8660
Hoch 0.0885 0.3010 0.4740 0.6705 0.7715 0.8660
m = 5
π0 = 0.6
MHoch 0.1580 0.3155 0.4340 0.5860 0.7045 0.7875
Roth 0.1200 0.2365 0.3380 0.5165 0.6280 0.7275
Hoch 0.0605 0.2190 0.3365 0.5165 0.6280 0.7275
m = 5
π0 = 0.8
MHoch 0.0955 0.1815 0.2585 0.3615 0.4695 0.5535
Roth 0.0745 0.1330 0.1920 0.2970 0.3965 0.4870
Hoch 0.0330 0.1190 0.1920 0.2970 0.3965 0.4870
m = 10
π0 = 0.2
MHoch 0.3215 0.6155 0.8110 0.9130 0.9765 0.9930
Roth 0.2080 0.4685 0.7225 0.8555 0.9420 0.9820
Hoch 0.1580 0.4660 0.7225 0.8555 0.9420 0.9820
m = 10
π0 = 0.4
MHoch 0.2735 0.5245 0.7200 0.8465 0.9450 0.9755
Roth 0.1770 0.3840 0.6070 0.7720 0.8920 0.9510
Hoch 0.1240 0.3795 0.6065 0.7720 0.8920 0.9510
m = 10
π0 = 0.6
MHoch 0.2030 0.4045 0.5615 0.7310 0.8450 0.9045
Roth 0.1335 0.2910 0.4525 0.6315 0.7600 0.8530
Hoch 0.0800 0.2825 0.4525 0.6315 0.7600 0.8530
m = 10
π0 = 0.8
MHoch 0.1135 0.2440 0.3500 0.4780 0.6150 0.6935
Roth 0.0765 0.1625 0.2645 0.3810 0.5175 0.6075
Hoch 0.0390 0.1555 0.2645 0.3810 0.5175 0.6075
m = 15
π0 = 0.2
MHoch 0.3405 0.6720 0.8830 0.9505 0.9915 0.9965
Roth 0.2520 0.5010 0.7545 0.8910 0.9765 0.9900
Hoch 0.1390 0.4875 0.7535 0.8910 0.9765 0.9900
m = 15
π0 = 0.4
MHoch 0.2895 0.5830 0.7925 0.9025 0.9635 0.9830
Roth 0.2110 0.4115 0.6485 0.8060 0.9335 0.9745
Hoch 0.1030 0.3870 0.6470 0.8060 0.9335 0.9745
m = 15
π0 = 0.6
MHoch 0.2150 0.4500 0.6595 0.7935 0.8845 0.9505
Roth 0.1495 0.3080 0.5095 0.6730 0.8320 0.9150
Hoch 0.0700 0.2760 0.5075 0.6730 0.8320 0.9150
m = 15
π0 = 0.8
MHoch 0.1210 0.2645 0.4285 0.5500 0.6730 0.7780
Roth 0.0835 0.1785 0.3055 0.4295 0.5895 0.7035

















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































PROOFS IN CHAPTER 3
This appendix contains the proofs of the theorems and lemmas stated but not proved
in Chapter 3.
B.1 Proof of Theorem 3.1
Proof. Let I0 denote the index of true null hypothesis, n0 = |I0| denote the number of
true nulls, R denote the the number of rejected hypothesis. Denote I = 1 if the first
true null hypothesis H1 is rejected.
Without loss of generality, replace first true null p-value by 0 and order the p-values
such that p1 = 0 ≤ p2 ≤ · · · ≤ pn. Let J = max{k : pk ≤
k
n
α}. Since the number
of rejections R is a non-increasing function of each p-values, R = R(p′1, p
′
2, . . . , p
′
n) ≤
R(p1, p2, . . . , pn) ≤ J(0, p2, . . . , pn) = J .





α. For 1 < r ≤ J , there are three cases as
the inflation factor br and b1 vary as follows.






























































Based on the above analysis, we can conclude I = 1 implies p′r ≤
J
n
α for r ≤ J ,
that is, at least J conditional p-values are no more than
J
n
α. Since R is the maximal
number r satisfying p′r ≤
r
n














































Then the proof is complete.
B.2 Proof of Lemma 3.1

















































−t/2, where the first
















If p′j = pj, then it is trivial that p
′

















Therefore, for any 1 ≤ j ≤ n − 1, if pj ≤ pj+1, then p′j ≤ p′j+1, the proof is
complete.
B.3 Proof of Theorem 3.2
Proof. By using similar arguments as the proof of Theorem 1, we can conclude reject





α. For 1 < r ≤ J , we also consider the
following three cases.
• Case 1: br = 1.










• Case 2: br = t < 1.
br = t implies min{p1, p2, . . . , pr−1, pr+1, . . . , pn} = min{p1, p2} > t, which means
p1 > t. Since p1 ≤
J
n
α ≤ α and α ≤ t, p1 ≤ t, which leads to a contradiction.




r ≤ J , that is, at least J conditional p-values less than or equal to J
n
α. Since R is the
maximal number r satisfying p′r ≤
r
n
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